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ABSTRACT

This dissertation focuses on providing quantitative insights regarding kinetic,
thermodynamic and mechanistic parameters of neuropeptide S-nitrosylation by nitrous
acid (HNO2), peroxynitrite (ONOO-) and S-nitroso-N-acetyl-D,L-penicillamine (SNAP) to
produce S-nitrosothiols (SNOs). Peptide thiol stability and the formation of SNOs from
neuropeptides; arginine vasopressin (AVP), somatostatin-14 (SST-14) and urotensin II (UII) was studied. Investigations into the effects of temperature, copper chelators and pH on
peptide thiol autoxidation show that AVP, SST-14 and U-II thiols have half-lives of 30, 44
and 28.2 mins respectively at physiologically relevant temperature and pH in the absence
of metal chelators. Target peptide thiols were shown to have half-lives sufficient for
subsequent S-nitrosylation reactions. The stability of peptide thiol in physiologically
relevant conditions suggests novel peptide thiol-mediated chemical signaling mechanisms.
We report the formation of S-nitrosothiols: AVP(SNO), SST-14(SNO) and U-II(SNO)
through HNO2/NO+ mediated S-nitrosylations. Reported bimolecular rate constants
suggest that HNO2 and NO+ would be the predominant nitrosating agents at low pH.
Kinetic and EPR analysis implicated copper redox cycling mechanism as catalysts for SNO
formation and decomposition. The release of NO during SNO decomposition suggests a
potential role for SNOs as efficient NO carrier and donors. Peroxynitrite reactions with
peptide thiols showed a complex dependence of acid concentrations with lower
bimolecular rates at physiological pH. We present peptide thiols as good candidates for
further studies as a peroxynitrite detoxifying compounds. Highly negative activation
entropies are reported for SNAP transnitrosation reactions with rate-limiting steps that are
i

characterized by a relatively ordered associative transition state. These activation
parameters suggest low energy barriers for transnitrosylation under physiological
conditions and support growing evidence that transnitrosylation may be a viable
posttranslational mechanism for NO transport in vivo. This dissertation proposes kinetic
reaction schemes, thermodynamics and mechanisms related to neuropeptide SNO
formation. Researchers can use these insights in the development of potential therapeutics
that target endogenous SNOs, and/or utilize synthetic SNOs to stimulate or inhibit NO
signaling. Kinetic models presented in this work can be used to infer the NO release profiles
of potential NO-donor based drugs by enhancing our understanding of the underlying
pharmacokinetics.
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CHAPTER 1: INTRODUCTION
1.1 Nitric Oxide: synthesis, signaling and toxicity.
1.1.1 Nitric oxide synthesis and isoforms. Nitric oxide (NO), is a signaling molecule that
receives a lot of attention due to its role in pathologies like hypertension, stroke, and
neurodegenerative diseases1. More than 90,000 research articles on NO biochemistry have
been published since it’s discovery as the endothelium-derived relaxing factor (EDRF)
more than a 25 years ago2. The three isozymes of nitric oxide synthase (NOS) are
endothelial (eNOS), inducible (iNOS), neuronal (nNOS) NOS. Each of these isozymes
forms antiparallel homodimers3, with monomers that contain two primary domains; (i) a
N-terminal oxygenase region that consists of individual complements of heme and
tetrahydrobiopterin (BH4) that bind to L-arginine, (ii) and a C-terminal reductase region
that consists of binding sites for flavin adenine dinucleotide (FAD), flavin mononucleotide
(FMN) and nicotinamide adenine dinucleotide phosphate (NADPH). These primary
domains are linked to another domain that binds to calmodulin (CaM). CaM (an acidic
Ca2+ binding protein) has been implicated in physiological processes like cell defense,
neurotransmission, cell proliferation and apoptosis 4. An essential process in the production
of NO from L-arginine, involves inter-subunit electron transfer between the reductase and
oxygenase domains which is facilitated by binding to CaM5. The oxygenase domain then
catalyzes the transformation of L-arginine to L-citrulline whilst also producing NO in two
steps: (1) production of N-hydroxy-L-arginine (NOHA) as an intermediate, and (2)
formation of L-citrulline through NOHA oxidation (Scheme 1.1)6-9. Regardless differences
in isozyme Ca2+ dependence, electron transfer in all NOS homodimers is initiated by the
1

binding of CaM to the central linker region and ensues in trans from NADPH through the
FAD/FMN subunit and finally to a heme iron subunit 5, 10.

Scheme 1.1: NO biological production (Reprinted with permission from Safia Habib)11

The NOS isoforms have unique expression patterns and enzymatic activity (Table 1.1)1214

. Various studies exploring NO signaling in the hippocampus, cerebellum, and cortex,

generally agree that NO is essential for long-term potentiation, which is the most
researched neuronal analogous of learning in vitro 15-18. The isoform nNOS is exceptionally
equipped to produce NO in a way that promotes synaptic plasticity
2

19-20

. NO is known to

enhance the synaptic effectualness of active neighboring neuronal axonal arbors, while also
weakening inactive axonal arbors. The central nervous system’s (CNS) capacity to regulate
local circuit neurons is closely related to its role as a principal source of NOS 20-23.
nNOS is anchored to the cytoskeleton in postsynaptic boutons underneath the glutamate
N-methyl-D-aspartate receptor ( NMDA-R), through an amino terminus that is not present
in the other NOS isozymes24. NMDA-R is linked to cognitive learning and other modes
of excitotoxic neurodegeneration25.

NMDA-R is activated when neurons are firing

frequently (few milliseconds) and partially depolarized resulting in localized increases in
NO production. Several studies have shown that Ca2+ entering through the NMDA-R
activates nNOS with subsequent NO production, which then activates soluble guanylyl
cyclase (sGC) and increases cyclic guanosine monophosphate (cGMP) levels

26-27

. This

functional coupling of NMDA-R, nNOS, and sGC led researchers to propose that they must
be located near each other and at glutamatergic synapses. Further studies revealed that
nNOS actually binds to a scaffolding protein now known as postsynaptic density protein
95 (PSD95), which anchors NMDA-R at the postsynaptic membrane 28-31. Olthof et al.,32
were the first to publish images of a multiprotein complex in the inferior colliculus (IC; a
sensory structure that constitutively produces high levels of nNOS) with all four proteins
(nNOS, NMDA-R, sSG and PSD95,) 33-35. The multiprotein complex was found to be in
apposition to vesicular glutamate transporters (VGluTs); VGluT1 and VGluT2 (Fig 1.1).
Glutamate binding to the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptor is proposed to activate NMDA-R, which allows Ca2+ ions to enter the
cell leading to NO synthesis through nNOS activation.
Such evidence of previously undescribed nNOS puncta in a domain originally thought to
3

be void of nNOS, emphasizes our limited understanding of the expression of NOSs and
should lead to studies of NO signaling in other unreported tissues.

Figure 1.1: NO signaling is linked to NMDA-R activation in the inferior colliculus (IC) (Reprinted with
permission from Bas M.J Olthof).

Dysregulation of nNOS expression is linked to CNS disorders such as Parkinson’s disease
(PD), amytrophic lateral sclerosis (ALS) and borderline personality disorder (BPD)36-38.
Disease pathologies like chronic renal failure, heart failure, and diabetes mellitus39 are also
associated with nNOS dysregulation, therefore the key to novel therapeutic strategies might
be dependent on further elucidation of nNOS signaling mechanisms.

4

Table 1.1: NOS Isoforms40

Of the three known isoforms of NO, iNOS over expression in disease states is believed to
be the most detrimental due to iNOS’s ability to produce excess NO. In macrophages,
iNOS produces bolus amounts of NO that directly causes DNA strand breaks in parasitic
microorganisms and tumor cells. NO also binds to protein-bound iron which inhibits
numerous iron-sulfur cluster-dependent enzymes41-42. The life span of induced
macrophages is largely dependent on NO; because in order to be cytotoxic to other cells,
macrophages have to be more resistant to NO than their target cells43. Studies have shown
that most macrophages are resistant to endogenously generated NO but are hypersensitive
to exogenous NO44. Therefore, unique pathways must exist through which exogenous NO
induces apoptosis in otherwise resistance cells. Exploiting such a mechanism, could allow
for targeted apoptosis as a way of eliminating cancerous cell growth. However, the
biochemical basis of these unique NO signaling pathways are not known yet, which is a
further testament to the complexities of NO signaling mechanisms.
5

The effects of iNOS function are widespread and further complicated by the fact that iNOS
is expressed by both immune and non-immune cells36, 45. Much attention has been focused
on iNOS expression by T cells with an emphasis on exploring how iNOS regulates immune
cell activity by nitrating crucial molecules associated with signaling pathways46-48. T-cell
expression of iNOS is known to downregulate Th17 differentiation with no effect on Th1
or Th2 cells (Fig 1.2A), this is consistent with reports that also implicate NO donors; Snitrosoglutathione (GSNO) and diethylenetriamine NONOate (NOC-18) in inhibiting
Th17 cell differentiation49-50. Incidence of inflammatory bowel disease (IBD), is also
linked to iNOS mediated modification of the transcription factor IRF5 which inhibits
classical pathway-activated macrophages (M1) polarization, without any significant effect
on alternatively activated macrophages (M2) polarization (Fig 1.2B)51-53. Innate immune
responses are dependent on iNOS expression profiles which modulate M1 gene expression
and de-differentiation.
Effector dendritic cells promote pathogen clearance by secreting cytokines which activate
an adaptive immune response

54

. Upregulation of iNOS expression inhibits effector

dendritic cells differentiation (Fig 1.2C), thereby suppressing the expression of receptors
involved in detecting pathogen-associated molecular patterns (PAMPs)

55-56

. Research

aimed at understanding regulatory mechanisms associated with DC-intrinsic iNOS
expression could facilitate the development of powerful medicinal strategies for immune
and inflammatory disorders.
In tumorigenesis, iNOS expression is upregulated thus producing more NO which is then
used by myeloid-derived suppressor cells (MDSCs) to initiate antitumor immune responses
(Fig 1.2D) and promotes antimicrobial activity by stimulating the expression of tumor
6

necrosis factor producing DCs (Fig 1.2E) 57.

Figure 1.2: iNOS regulates the expression of various immune cells and responses. Arrows ↓: decreasing
expression; ↑: increasing expression. Graphic from Xue et al., 2018 58.

It is still unknown if iNOS is expressed by all immune effector cells, therefore the extent
to which NO regulates immune response is unclear. Future studies should aim to elucidate
iNOS-derived NO regulatory mechanisms as this shed more light on the role of NO in
autoimmune and inflammatory disorders.
Endothelial cells constitutively express eNOS in cardiac myocytes, renal tubular epithelial
cells and platelets59-60. eNOS mediated NO release modulates endothelium-dependent
hyperpolarizations (EDH), which control vascular tone and the release of numerous
7

vasoactive molecules

61-66

. Agonists like histamine interact with receptors on endothelial

cell membranes to stimulate increased production of intracellular calcium (Ca2+). The Ca2+
activates the calmodulin-binding motif of eNOS to release NO by binding to calmodulin
(CaM). eNOS activation can be through calcium-dependent or independent pathways
(Fig1.3a). Fluid shear stress and phosphorylation and known to regulate eNOS mRNA and
eNOS protein expression in the absence of Ca 2+ 67-69. Phosphorylation based modulation
of eNOS activity is site-specific as phosphorylation on distinct sites Thr495 and
Ser635/Ser1177 result in inhibition and activation respectively70-71. Bradykinin also
stimulates eNOS to release NO through phosphorylation and dephosphorylation processes
on sites Ser1177 and Thr495 respectively72. Whilst shear stress has been reported to
promote eNOS phosphorylation on site Ser1179 in a protein kinase A-dependent manner7374

. NADPH-cytochrome P450 reductase (CPR) reduces NO3- to NO in endothelial cells,

which is considered an essential mechanism in replenishing NO levels during eNOS
dysfunction as typically seen in patients with cardiovascular risk factors (Fig 1.3b)

75-76

.

Various factors ranging from oxidative stress to eNOS uncoupling have been implicated in
eNOS dysfunction. Oxidative stress alters eNOS function from releasing NO to generating
superoxide anions. Reactions between NO and the superoxide anion form peroxynitrite
(ONOO−) which is an extremely potent oxidant that alters the functions of numerous
intracellular molecules77.
eNOS uncoupling can be due to ONOO− mediated BH4 oxidation in a cycle that leads to
further uncoupling of eNOS from BH4 and production of more superoxide anion (Fig
1.4)78-79. Depletion of L-arginine, S-glutathionylation and the build-up of autogenous
methylarginines can also result in eNOS uncoupling 80-81.
8

Despite extensive studies82-84, electron transfer processes between NOSs and holoenzyme
CaM are poorly understood. Kinetic studies on holo CaM binding rates to nNOS and
iNOS peptides using surface plasmon resonance (SPR) reported bimolecular rate constants
of 1.58 × 105 M−1s−1 and 3 × 104 M−1s−1, respectively85. These rates implied a slow ratelimiting holo CaM binding process, which is contrary to heme binding rates in NOS
catalysis making is plausible that immobilizing NOS peptides on the SPR matrix could
have curtailed binding rates86-87. Almost two decades later, Gang Wu et al., determined
CaM to NOS binding rates using fluorescence stopped flow to be ~4 orders of magnitude
greater than those evaluated on a SPR matrix88. McMurry et al., employed interferometry‐
based biosensors to measure association (kon) and dissociation (koff) rates for CaM binding
to endothelial and neuronal NOS88. Their data suggests rates CaM binding rates that are
essentially diffusion limited within ~3 orders of magnitude of Smoluchowski diffusion
coefficients as defined by the Einstein–Smoluchowski diffusion equation. Phosphorylation
of CaM‐binding sites greatly decreases CaM/NOS binding rates and as a general rule;
changes in Ca2+ concentrations modulate CaM/NOS affinities.
NOS isozymes are excellent heme-binding ligands that produce NO which binds to the
heme before its released into the physiological milieu 89. Therefore, an essential aspect of
deciphering NOS activity must include the determination of five pivotal kinetic parameters
that regulate NO production and release from NOS. As illustrated in scheme 1.1, two
sequential steps constitute NOS mediated NO production with rate constants kcat1 and kcat2
respectively (Fig 1.5). A ferric heme–NO complex is formed which can either undergo
reduction or dissociation with rate constants kr and kd respectively.

9

Figure 1.3: (A) eNOS can be activation through various calcium dependent/independent pathways.
(B) NO is also produced through cytochrome P450 reductase mediated NO3- reduction. Graphic
from Zhao et al., 2015 90.

Reduction of ferric heme–NO forms a ferrous complex that can reform the ferric NOS
isoenzyme through a reaction with O2 with a rate constant; kox. Ray et al., determined
temperature dependencies of these rate constants using single-turnover kinetic
10

measurements, computer simulations and stopped-flow spectroscopy91.

Figure 1.4: Processes leading to peroxynitrite production and eNOS uncoupling in endothelial cells. Grey
arrows indicate physiological processes, whilst red arrows depict pathological processes. Graphic from
Leiper et al., 2007 78.

The study proposes a global kinetic model aimed at providing a detailed understanding of
how steady-state NO generation is affected by factors like O2 concentration, temperaturedependence of catalytic activity and NOS specific activity (Fig 1.5). The model depicts
reduction of NOS isoenzyme with ferric heme (kr) followed by binding of O2 to the ferrous
heme to form of a FeIIO2 species. Two sequential steps with rate constants; kcat1 and kcat2,
converts the FeIIO2 species to products in L-arginine and N(omega)-hydroxy-l-arginine
oxidation reactions that ultimately form a FeIIINO complex. The FeIIINO complex can
either undergo productive (kd) or futile cycles (kox) that either release or destroy NO
respectively. Thermodynamic parameters were then evaluated from these observed rate
constants allowing for the accurate modelling of nNOS regulation under physiologically
relevant conditions. Such integrated experimental approaches that use multiple analytic
techniques (resonance raman, stopped flow and electroparamagnetic resonance) are
11

essential in deciphering mechanisms that govern NOS regulation.

Figure 1.5: Kinetic model for nitric oxide synthase catalysis. Graphic from Ray et al., 2007 91.

1.1.2. NO diffusion, reactivity and signaling. Intracellular NO diffuses out of cells and
binds to heme-containing proteins, thereby modulating biological function. Under
physiological concentrations of oxygen, the NO radical is fairly unstable and rapidly
diffuses into the blood stream

92

. Nitric oxides ability to strongly bind heme is linked to

cyclic guanosine monophosphate (cGMP) activation through interactions with heme in
soluble guanylate cyclase (sGC). NO concentrations in the nanomolar range are required
to activate sGC. Once cGMP is activated, a down-stream cascade of reactions activates
cGMP-dependent kinases which in turn regulate Ca2+ levels in various tissues. Kinetic
modeling and steady-state approximation techniques, have implicated NO binding to heme
in cytochrome-c oxidase as the major process responsible for decreasing mitochondrial
respiration rates93. Despite having the ability to detect subtle deviations in molecular shape,
12

receptors in tissues are deceived by NO’s unique properties (one unpaired electron and two
atoms), which is the main reason why NO is implicated as a signaling molecule in various
physiological and pathophysiological signal transduction pathways94. The effects of NO
are localized and concentration dependent, as concentrations greater than one micromolar
result in reactive nitrogen oxygen species (RNOS) that are deleterious effects (Fig 1.6a).
Therefore, to mitigate the effects of excess NO build-up and prolonged sGC activation;
NO is removed by oxyhemoglobin 95-96. The heme: protoporphyrin IX in hemoglobin has
a great affinity for NO, with some reports stating that deoxyhemoglobin has a 104-fold
greater affinity for NO than O297-98. In vitro experiments show a steep diffusion gradient
between red blood cells (RBC) and intracellular NO, as RBC’s effectively remove NO
from cells and prevent reentry 99-101. The half-life of NO in conjunction with its ability to
diffuse across various cell membranes makes NO a major signal transduction messenger
molecule that modulates a plethora of physiological processes102.
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Figure 1.6: (a) Direct and Indirect effects of NO, (b) The interplay between nitric oxide, super
oxide, peroxynitrite and nitrogen dioxide. Graphic is adapted from Pacher et al., 2007 77.

1.2 Peroxynitrite chemistry in health and disease. NO cytotoxicity is largely due to
oxidation products like peroxynitrite (ONOO–), which are more stable and therefore
promote various nitration and oxidation processes (Fig 1.6b). As mentioned earlier, most
of NO’s cytoprotective effects are at low NO concentrations and this is mainly because NO
cannot out-compete superoxide dismutase (SOD) for superoxide at low concentrations103.
14

In excess NO concentrations, it reacts with superoxide to yield ONOO–, essentially
positioning NO as the sole biological molecule that can out-compete SOD, with a
bimolecular rate (6.7 x 109 M-1s-1) that is diffusion-limited

104

. The pKa of ONOO– and

peroxynitrous acid (ONOOH) is 6.8, thus under physiologically relevant conditions both
ONOO– and ONOOH coexist105. Coexistence of these species further complicate
peroxynitrite reactivity studies because ONOO− and ONOOH react differently.
Peroxynitrous acid is highly unstable in aqueous media, with a half-live of 0.6s at
physiologically relevant temperature and pH

106

. Beckman et al., reported •OH and •NO2

radical production during ONOOH decomposition and implicated these radicals in
processes that result in endothelial injury (scheme 1.2) 107. Peroxynitrite concentrations in
the nanomolar range are also linked to various disease phenotypes including
atherosclerosis, cancer, inflammation, and sepsis77, 108-109.

Scheme 1.2: Acid catalyzed peroxynitrite decomposition.

Peroxynitrous acid readily diffuses across cell membranes and decomposes to produce the
aforementioned secondary radicals resulting in undesired protein oxidation and nitration
reactions. Radi et al., using stopped-flow spectrophotometry were the first to report
bimolecular rate constants of ONOO− reactions with thiols that were faster than ONOO−
homolysis110. Earlier kinetic studies had suggested that direct reactions between ONOO–
15

and proteins were only possible with fast-reacting thiols in the presence of metal cofactors
111

. Surprisingly, their data showed rate constants of hydrogen peroxide reactions with

thiols which were ~3 orders of magnitude smaller than ONOO−/ thiol reactions. Elucidation
of these kinetic aspects of ONOO– mediated oxidations of biomolecules provided essential
insights about peroxynitrite’s quantitative relevance in biological systems. A major area of
contention between researchers in free radical biology involves the determination of
precise “quantities” of radicals generated in tissues and how to adequately account for these
when conducting in vitro experiments. To account for this, kinetic studies aim to make a
clear distinction between formation rates and steady-state concentrations112-114. Indirect
measurements of ONOO– formation rates in activated macrophages are estimated to be in
the micromolar range115-116. A comparison between kinetic estimates and biological
experimental data supports the conclusion that estimated ONOO– formation rates agree
with reported ONOO– cellular flux rates108. Alvarez et al., conducted exhaustive
experiments aimed at determining macrophage intracellular ONOO– concentrations that
are required for effective pathogen clearance117-119. Due to variations in how different cell
types generate and consume ONOO–, moderate estimates of ONOO– steady-state
concentrations

in

vivo

are

in

the

nanomolar

range120.

Another

essential

ONOO- detoxification pathway; is the nucleophilic addition of ONOO- to CO2 to yield
ONOOCO2-, which decomposes to form nitrogen dioxide and carbonate radicals (Fig 1.6b)
121-124

. Kinetic and mechanistic studies are especially well suited for probing ONOO-

properties and reaction conditions that modulate peroxynitrite specificity. Implementing
such a holistic approach would provide further insights into the fundamentals of ONOO mediated reactions and assist in the development of therapeutic tools aimed at attenuating
16

peroxynitrite’s cytotoxic effects.

1.3 Thiol biochemistry and S-nitrosylation. Thiols are highly nucleophilic organosulfur
compounds that play fundamental roles in protecting cells from oxidative stress and
nitrosative injury125-127. Cysteine is a unique canonical amino acid which is a major
component of protein structure through the formation of cystine disulfide bridges

128

.

Cysteine residues also facilitate metal ion coordination and maintain redox homeostasis
within cells129. Cysteine residues are known to form mixed disulfides and are readily
oxidized by ROS to sulfenic acid in a reaction called S-sulfenylation (Fig 1.7). Subsequent
two electron oxidation reactions can result in sulfinylation and sulfonylation respectively
with the latter being irreversible130. Palmitate (an ester of palmitic acid) forms covalent
thioester bonds with cysteine in a post-translational modification called palmitoylation131.
Since cysteines have pivotal structural and regulatory functions, posttranslational
modifications are often linked to protein dysregulation and various acquired and hereditary
disorders

132

. Therefore, unraveling molecular mechanisms associated with the post-

translational modification of key amino acids (like cysteine residues) is of paramount
importance in enhancing our understanding of protein function and dysregulation.
Of particular interest in this dissertation is S-nitrosylation/S-nitrosation; the covalent
bonding of NO to cysteine form S-nitrosothiols (RSNOs). Some examples of naturally
occurring RSNOs are S-nitrosoglutathione (GSNO) and S-nitrosocysteine (CySNO)133-134.
It is now widely accepted that S-nitrosylation is a significant post-translational
modification that regulates cellular signal transduction mechanisms of various types of
proteins 135-137.
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Figure 1.7: Main redox modifications of cysteine residues. Graphic from Fra et al. . ., 2017 138

S-nitrosylation chemical reactivity is independent of substrate-enzyme recognition but
solely relies on interactions between the nitrosylating agent and peptide/protein thiols 139140

.

Three main factors that are essential in regulating S-nitrosylation specificity include (i)
peptide/protein residue reactivity, (ii) local concentrations of peptide/protein thiols and the
S-nitrosylating agent and finally (iii) stability of the S-NO bond.
(i) Peptide/protein residue reactivity. Studies have shown that not all peptide/protein thiols
are S-nitrosylated, however elucidating the structural motifs that make some thiols more
18

susceptible to S-nitrosylation than others is still a hot area of research141-142. Generally,
formation of RSNOs is favored in more ionizable cysteines, where the nucleophilic thiolate
ions are stabilized by redox reactions with adjacent residues143-144. Cysteine residue pKa
determines thiol reactivity as amino acid conformation changes in response to cellular
conditions.
(ii) Local concentrations of peptide/protein thiols and the S-nitrosylating agent. Snitrosylation relies on the formation of RNS (HNO2, NO2-, ONOO-, NO+), since NO itself
is not the main S-nitrosylating agent145-147. Chemical reactivity is largely dependent the
concentrations of both the peptide/protein thiols and S-nitrosylating agent, with are
functions of kinetic and thermodynamic parameters. Therefore, one cannot overstate the
importance of co-localization of NO and target thiols in subcellular compartments, as a
pivotal factor in identifying S-nitrosylable proteins148-151.
(iii) Stability of the S-NO bond. Cleavage of the labile S-NO bond in S-nitrosothiols occurs
primarily through heterolytic or homolytic bond cleavage, whilst enzymatic cleavage have
been reported for some low molecular weight S-nitrosothiols at high Michaelis constant
values148. S-NO bond cleavage is accelerated by some transition metals like copper 152.
Transnitrosation (NO exchange between thiols) is another mechanism for S-NO bond
cleavage. Kinetic studies of transnitrosation reactions between low mass thiols and NO
donors, report a fast reaction at physiological pH 153. The relative ease of transnitrosation
under physiologically relevant conditions, suggests a role for peptide thiols as NO
reservoirs that are relatively stable on a time scale that allows peptide S-nitrosothiols to
modulate physiological processes. Denitrosylation is believed to be an essential signal
19

transduction mechanism, however not much work has been done in this area154-155. Despite
growing evidence that implicates protein/peptide S-nitrosothiols as biologically significant
NO signaling molecules, kinetic and thermodynamic parameters of peptide S-nitrosothiols
formation and denitrosylation are yet to be fully explored.
1.4 Overarching goals and aims of this study. S-nitrosylation of peptide and/or protein
residues produces S-nitrosothiols (SNOs) that are associated with modulating the functions
of various peptides. Co-localization of neuropeptide oxytocin (OT) with neuronal nitric
oxide synthase (nNOS) (which produces NO facilitating synaptic plasticity) in the
hypothalamo-neurohypophyseal network, has been linked to OT S-nitrosylation in vivo.
Additionally, both the reduction and S-nitrosylation of OT disulfide is believed to illicit a
decentralized, temporal, and site-specific alteration of OT hormonal sensory activity as
OT–(SNOs) could alter signaling pathways through chemical modification of OT
receptors. S-nitrosylation and de-nitrosylation are believed to have roles as predominant
effector mechanisms implicated in disrupting cellular redox homeostasis, thus resulting in
various pathophysiological conditions. Our limited understanding of S-nitrosylation/denitrosylation mechanisms has hampered the development of therapeutic strategies for
remedying aberrations in protein conformation and protein-protein interactions as a result
of this reversible post-translational modification.
The overarching goal of this project is to decipher the kinetics, thermodynamics and
mechanisms of neuropeptide SNO formation, which would fill missing gaps in
contemporary research. We aim to develop a protocol and kinetic models that will be used
to elucidate the energetics and mechanisms of neuropeptide SNO formation. This work
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will focus on providing a quantitative understanding of SNO formation from three
neuropeptides namely; arginine vasopressin (AVP), somatostatin-14 (SST-14) and
urotensin II (U-II).
Peptide thiols are known to have unique autoxidation rates which largely depend on amino
acid sequence, peptide structure and cellular redox conditions. We hypothesize that target
peptide thiols have half-lives sufficient for subsequent S-nitrosylation reactions under
physiologically relevant conditions. To test this hypothesis, we will evaluate the effects of
temperature, copper chelators and pH on peptide thiol autoxidation to ascertain the
formation and stability of target peptide thiols under physiologically relevant conditions.
The second hypothesis is that S-nitrosylation of target peptide thiols by NO moieties is
both kinetically and thermodynamically favorable under physiological conditions and
peptide SNOs are efficient carriers of NO. This study will determine the kinetics and
thermodynamic parameters for target peptide S-nitrosylation by nitrous acid, peroxynitrite
and SNA using Stopped-flow spectrophotometry. The determination of rate constants at
different temperatures allows for the calculation of enthalpy, entropy, Gibbs free energy
and activation energies for S-nitrosylation reactions.
Our final hypothesis is that peptide S-nitrosylation produces radicals and SNOs that may
modify peptide function by altering peptide-receptor interactions and signaling pathways.
Identification of radical/non-radical pathways elucidates molecular mechanisms that will
enhance our understanding of S-nitrosylation/de-nitrosylation mechanisms which would
aid in the development of therapeutics. This study will use electroparamagnetic resonance
(EPR) to investigate radical formation and structure-activity relationships infer novel
peptide SNO.
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CHAPTER 2: INSTRUMENTATION, MATERIALS AND METHODS
2.1 INTRODUCTION
Elucidation of kinetic parameters and mechanisms involved in complex biological
reactions requires the identification of rate limiting steps, intermediates, and reaction
products. Evaluations of the effects of variations in concentration, rate dependence,
temperature and pH are essential. Specialized instrumentation and analytical techniques
are required when reaction time scales are rapid, and the half-lives of intermediates and
products are short lived. Specialized equipment, methods and techniques described in this
chapter include UV/Vis spectrophotometry, electron paramagnetic resonance, high
performance liquid chromatography (HPLC), stopped-flow spectrophotometry and mass
spectrometry.

2.2 INSTRUMENTATION
2.2.1

UV/Vis Spectrophotometry

A Perkin Elmer Lambda 25 spectrophotometer with halogen and deuterium lamps (190 to
1100 nm) was used to monitor reaction progress for slower reactions (>120s timescale).
The Perkin-Elmer UV WinLab software was used for data capture, archiving and analysis.
Constant parameters during data capture include a cuvette path length of 1 cm and a
temperature of 25 oC. Temperature variation experiments were carried out by coupling a
NESLAB RTE101 thermostated water bath recirculatory to the Perkin Elmer Lambda 25
spectrophotometer.

22

2.2.2

Stopped-flow Spectrophotometry.

Stopped-flow spectrophotometers are especially well-suited for monitoring rapid reactions
with reaction solutions in the flow cell having a dead time of approximately 0.3 ms. Rapid
reactions with a timescale of less than 120 s were monitored with a Hi-Tech Scientific
SF61-DX2 double mixing stopped-flow spectrophotometer. The double mixing feature of
the stopped-flow spectrophotometer allows for the mixing of reactants in reservoirs A and
B facilitating the in-situ production of an unstable reactive intermediate like nitrous acid
or peroxynitrite. After a short time delay, reactants from reservoirs C and/or D are
introduced to the solution containing the reactive intermediate until a steady-state flow is
attained. The final solution with a millisecond dead time is funneled through to a flow cell
by a stopping syringe where the flow is stopped allowing for the measurement of cell
optics. Employing appropriate techniques, reaction kinetics can be determined thus
providing a method for the expeditious mixing of reactants coupled with immediate
analytical signal generation.
2.2.3

Chromatography and mass spectrometry

A Phenomenex Synergi Fusion-RP (4 µm) HPLC column connected to an HP Agilent
Series II 1090 HPLC was used for chromatographic separations. Solvents acetonitrile and
water in 0.1 % formic acid were used to prepare mobile phases A and B, comprising of 10
% and 90 % acetonitrile respectively. A gradient elution of 0−30 % for mobile phase B at
flow rates between 0.5 mL min -1 was employed for all peptide sample analysis. A diodearray detector at wavelengths 280 nm and 545 nm was used for monitoring peptide and Snitrosothiol signals respectively. A Micromass Q-TOF II LC/MS/MS Hybrid Quadrupole
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TOF mass spectrometer in positive-ion mode was used for product identification in peptide
disulfide reduction experiments. Mass spectrometry samples were rendered in 50:50 water
and acetonitrile solution then subsequently injected through capillary tubing at flow rates
ranging from 1 – 1000 μL min -1. A high voltage of 3200 V was applied directly to a
stainless-steel capillary emitter contained in the ionization source. Nebulizing nitrogen gas
at the tip of the capillary emitter creates an electric field that promotes solvent evaporation
forming charged droplets. The nitrogen gas (kept 150 °C and injected at flow rate of 1 μL
min -1) also aids in directing the spray of droplets through the cone (35 V) towards the mass
analyzer. Collision-cell, TOF voltages and source block temperatures were maintained at
10 V, 9.1 kV and 80 °C respectively.
2.2.4

Electron Paramagnetic Resonance (EPR) Spectroscopy.

A Bruker EMX EPR Spectrometer was used for the detection of short-lived hydroxyl and
nitric oxide radicals using 5,5-dimethyl-1-pyrroline N-oxide (DMPO) and nitroethane
spin-traps respectively. Plank’s law states that absorption of electromagnetic radiation
results in different energy states occurring, with the energy difference (the Zeeman effect)
being equal to the product of Planck’s constant (h) and microwave frequency (ν). The
microwave energy (∆E) is also equal to the product of the Bohr magneton (β), the
spectroscopic splitting constant; g-factor (g) and the magnetic field (H). Our X-band EPR
held the frequency of radiation constant at 9.78 gigahertz (GHz), while varying the
magnetic field used to acquire absorption spectrum. When radical species (with one
unpaired electron) are placed in a magnetic field, absorption of electromagnetic radiation
occurs when the electron transitions to a higher energy state. The two spin states have
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different energies that would increase linearly with an increase in the magnitude of the
applied magnetic field.
The amount of EPR active adduct formed is directly proportional to the intensity of the
signal detected by the EPR. Spectra band width, line shape and hyperfine splitting are
essential parameters that are used to identify various radical species. All EPR
measurements were carried out at standard room temperature and pressure. The following
EPR setup used in this study was adapted from Morakinyo, (2010), “microwave power,
19.91 mW; modulation amplitude, 1.41 G; receiver gain, 448; time constant, 10.24 ms;
sweep width, 100 G and frequency, 9.78 GHz”156.

2.3 MATERIALS
Three neuropeptides; Arginine vasopressin (AVP: Cys-Tyr-Phe-Gln-Asn-Cys-Pro-ArgGly), Somatostatin-14 (SST-14: Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-ThrSer-Cys) and Urotensin-II (U-II: Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Try-Cys-Val) were
purchased from Sigma Aldrich. Peptides were used without further purification at a purity
of approximately 95%. Peptides were chosen on the basis of known physiological functions
and the presence of chromophores whose reaction progression can be followed using
spectroscopic and stopped-flow techniques. These analytical chemicals were purchased
from Sigma Aldrich: formic acid, tris(2-carboxyethyl) phosphine (TCEP) gel, sodium
nitrite (99.5%), phosphate buffered saline (PBS) tablets, a mMonium formate, hydrogen
peroxide solution (30% w/w), DMPO (5,5- dimethyl-1-pyrroline-N-oxide), sodium
hydroxide, ethanol (>99%), perchloric acid (70-72 %), acetonitrile (ACN), neocuproine
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hydrochloride, manganese dioxide and sodium perchlorate. Nitrous acid (HNO2)
[nitrosating agent 1], was formed in situ by reacting sodium nitrite and perchloric acid. A
quenched flow reactor comprising of a syringe pump, 30 mL disposable syringes and two
tygon tubing connectors was used to synthesize peroxynitrite (ONOO-) [nitrosating agent
2]. Solutions of 0.7 M HClO4 and 0.6 M NaNO2 reacted through the first T junction tubing
connector to produce nitrous acid (HNO2) which was then pumped into a flask containing
0.7 M H2O2 resulting in the formation of the yellowish colored peroxynitrous acid
(ONOOH). The reaction was then quenched by introducing a 1.5 M NaOH solution through
the second T junction tubing connector at a flow rate of 17 mL min -1. Granular manganese
dioxide was used to remove excess H2O2 from the ONOO- solution, and standardization at
302 nm (Ƹ320 = 1670 M-1 cm-1) was carried out using spectrophotometric and iodometric
techniques. Fresh peroxynitrite was prepared daily. SNAP (S-Nitroso-N-acetyl-DLpenicillamine) [nitrosating agent 3], was purchased from Sigma Aldrich as a powder with
≥97% purity.

2.4 EXPERIMENTAL METHODS
2.4.1 Peptide thiol formation, isolation, and identification. To establish conditions needed
for complete disulfide reduction, a spin column was filled with an 8 mM suspension of
TCEP-gel in distilled water followed by centrifugation at 4000 rpm. Distilled water was
collected in Eppendorf tube and discarded. A 200 µL aliquot of a 2 mg mL-1 peptide
disulfide solution in water was incubated with the gel for 15 to 120 mins with continuous
agitation by vortexing at the lowest intensity. Agitation prevented the gel from settling to
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the bottom of the column, which would result in incomplete disulfide reduction. Peptide
dithiols were collected in the Eppendorf tube by spinning the column at 4000 rpm for 90
o

C at 4 oC and 10-fold diluted aliquot was analyzed by HPLC to confirm complete disulfide

reduction. TCEP was either washed, re-suspended in water and stored at 4 oC or discarded.
All peptide dithiol samples are frozen at -80 oC until use.
2.4.2 Peptide thiol stability. Using HPLC the stability of peptide thiols was evaluated by
monitoring the rate of disulfide reformation over time. The effects of temperature, pH, and
the presence of trace copper impurity on peptide disulfide reformation were examined. A
stock of 1 mM peptide dithiol in water was prepared and aliquots of this sample were
further diluted to 250 µM in the appropriate buffer. Samples were removed at different
time points and diluted to 25 µM before being injected into the HPLC column. The
temperature dependence of disulfide reformation was examined by incubating samples of
peptide dithiols at 21, 37 and 50 oC. Peptide thiol stability was also compared in water (pH
3.0) and in 30 mM PBS buffer at pH 7.4. Copper catalysis of disulfide reformation was
evaluated using two copper-specific chelators: neocuproine (Cu+) and DTPA (Cu 2+). The
thiol and disulfide peaks in the various HPLC chromatograms were integrated to obtain
calculated peak areas. The percent disulfide reformation was determined from the thiol
peak areas divided by the sum of the thiol and disulfide peak areas multiplied by 100. Since
peptide disulfides can reform very quickly under specific conditions and also because the
injection into the HPLC might be delayed, two measures were taken in order to limit
peptide disulfide reformation between aliquoting and analysis. Firstly, experiments run in
30 mM PBS at pH 7.4, contained 100 - 200 µM neocuproine and DTPA, since the redox
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properties of the copper are known to favor disulfide formation between thiols. Secondly,
all samples were kept in a refrigerated (4 oC) HPLC tray before injection.
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CHAPTER 3: KINETICS AND MECHANISMS OF ARGININE VASOPRESSIN
S-NITROSYLATION BY NITRIC OXIDE

3.1 INTRODUCTION
Vasopressin is an oligopeptide produced in the hypothalamus and it comprises of only nine
amino acid residues. It is essential for osmoregulation, homeostasis and has also been
implicated in cognition and memory157. The human analog contains arginine and is thus
called arginine vasopressin (AVP). AVP is produced by both magnocellular [located in the
supraoptic (SON) and paraventricular nucleus (PVN)] and parvocellular hypothalamic
neurons. Numerous signals from perimetric organs prompt neurosecretory endings that are
positioned on distal axons of the pituitary gland to discharge AVP which then readily enters
the bloodstream because pituitary gland capillaries are devoid of a blood–brain barrier 158.
The three established receptors of AVP are: V1aR (V1a), V3 (V1b) and V2 (AVPR2).
V1aR receptors are expressed in vascular smooth muscle cells, adrenal medulla, brain, liver
and kidney

56, 159

. V1aR and AVPR2 receptors are known to mediate the effects of AVP

secretion on arterial blood pressure through a phospholipase C-mediated pathway and have
also been linked to AVP-mediated stress responses in rats and in humans

160-161

. V3

receptors are located in the anterior pituitary and mediate the release of the
adrenocorticotropic hormone (ACTH) which is stimulated by increases in AVP expression
also through the phospholipase C and adenylate cyclase-mediated pathways

162

. Long-

acting AVP analogs like triglycyl lysine vasopressin (Terlipressin) with a higher affinity
for V1aR and AVPR2 receptors are undergoing clinical studies for the treatment of
tachycardia with shock163. Histochemical studies have detected the presence of NOS in
29

SON and PVN nuclei located in the posterior pituitary gland, this colocalization of NOS
and AVP has also been linked to regulatory mechanisms that suggest an interplay between
AVP secretion and NOS activity

164-165

. In vitro and in vivo studies with AVP and NO

donors, show a correlation between the inhibition of NO synthesis and increased AVP
secretion 166-167. Despite mounting evidence of NO as a neuromodulator of AVP activity,
it is surprising that no kinetic, thermodynamic or mechanistic studies of biochemical
reactions between AVP and NO have been reported to date. It is therefore plausible that
AVP thiols might be targets of NO post-translational modification through S-nitrosylation
resulting in a steady state equilibrium with AVP S-nitrosothiols135,

168-169

. AVP S-

nitrosylation has the potential to alter S-nitrosothiol blood levels resulting in the
dysregulation of physiological and pathological processes which could culminate into
various pathophysiological disease states

170-174

. Peptide-peptide transnitrosylation

reactions have emerged as a distinctive mechanism by which NO can be transferred to
peptide thiols within the same vicinity as peptide S-nitrosothiol. Over 3000
peptides/proteins are S-nitrosylated in tissues with various outcomes including active-site
specific and allosteric cysteine thiols modifications which have been implicated in human
disease175-177. The rates of trans-nitrosation and the decomposition of S-nitrosothiols are
essential in elucidating nitrosylating/denitrosylating mechanisms and evaluating whether
peptide S-nitrosothiols are effective NO transporters.
This chapter gives a detailed kinetic, thermodynamics and mechanistic study of NO
mediated S-nitrosylation of AVP. Rate constants, energetics and AVP structural
modifications associated with S-nitrosylation reactions are investigated with the aim of
providing links to alterations in peptide function.
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3.2 RESULTS AND DISCUSSION
3.2.1 AVP dithiol formation and stability. A method for isolating pure AVP thiol
(AVP(SH)) was established using LC-MS, to probe whether vasopressin thiols are
kinetically stable under physiological conditions to allow for S-nitrosylation to occur.
Since certain amino acids (tryptophan and tyrosine and cysteine) are known to have
absorptivity in the UV at 280 nm, we used the absorptivity characteristics of cystine and
tyrosine residues in AVP disulfide to elute the peptide using an HPLC-UV chromatogram.
AVP disulfide reduction was achieved by incubating of 60 µM AVP disulfide dissolved in
distilled water with 2.5 M gel-bound TCEP (40-fold excess) for 30 min in a spin column
followed by centrifugation. TCEP was chosen due to its stability over a relatively broad
pH range (1.5–8)

178-180

. AVP disulfide and thiol forms were separated using HPLC-UV

(Fig 3.1A and B). Mass spectrometric (MS) analysis confirmed peak 1 (Fig 3.1A) as AVP
disulfide with singly protonated (M+H) + ions at m/z 1084.44 and the doubly protonated
(M+2H)2+ ions at m/z 542.72 (Fig 3.1C). Peak 2 (Fig 3.1B) was identified as singly
protonated (M+H) + AVP (m/z 1086.46) and the doubly protonated (M+2H)2+ AVP dithiol
at m/z 543.73 (Fig 3.1D). The effects of pH, copper chelators and temperature on the rate
of AVP thiol autoxidation was investigated in phosphate-saline buffer (PBS). Since trace
amounts of copper are known to accelerate disulfide reformation, we used Cu2+ and Cu+
metal chelators; diethylenetriaminepentaacetic acid (DTPA) and neocuproine respectively,
to investigate the effects of metal ions on thiol autoxidation181.
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Figure 3.1: HPLC-UV-MS analysis of AVP disulﬁde reduction. (A) An HPLC chromatogram of 60
µM AVP disulfide was run as a standard and eluted in peak 1 at 8.1 mins. (B) 60 µM AVP disulfide
in pH 3 water was incubated for 30 minutes in 2.5 M TCEP (40-fold excess), the product was eluted
in peak 2 at 11.9 mins. (C). ESI mass spectra confirmed peak 1 as AVP disulfide. (D) ESI mass
spectra shows peak 2 as AVP dithiol.

AVP thiol stability was investigated by monitoring the rate of disulfide reformation using
HPLC chromatograms at varying temperatures and pH, the effect of metal chelators. The
rate of disulfide reformation was evaluated using Eq 3.1.

% 𝑃𝑒𝑝𝑡𝑖𝑑𝑒 =

𝑃𝑒𝑝𝑡𝑖𝑑𝑒 𝑑𝑖𝑠𝑢𝑙𝑓𝑖𝑑𝑒 𝑝𝑒𝑎𝑘 𝑎𝑟𝑒𝑎
𝑥 100 𝐸𝑞 3.1
𝑃𝑒𝑝𝑡𝑖𝑑𝑒 𝑑𝑖𝑠𝑢𝑙𝑓𝑖𝑑𝑒 𝑝𝑒𝑎𝑘 𝑎𝑟𝑒𝑎 + 𝑝𝑒𝑝𝑡𝑖𝑑𝑒 𝑑𝑖𝑡ℎ𝑖𝑜𝑙 𝑝𝑒𝑎𝑘 𝑎𝑟𝑒𝑎
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The time course for > 95% AVP disulfide reformation is summarized in Table 3.1, which
shows that reducing temperature decelerates the rate of thiol autoxidation. Lowering pH
from 7.4 to 3.0 reduced the rate of disulfide reformation by a factor of 6 when compared
to the effect of chelators. These data agrees with previous studies showing that dithiol–
disulfide exchange reactions are disfavored under low pH conditions182. Copper chelators
have an inhibitory effect on disulfide reformation, as solutions at pH 7.4 containing
chelators had > 20-fold inhibition of disulfide reformation. AVP thiol was shown to have
a half-life of 29.5 min at physiological temperature and pH.

Table 3.1: The effects of temperature, pH and metal chelators on time required for AVP
disulfide reformation.

3.2.2 Nitrous acid mediated S-nitrosylation and product identification. Researchers have
identified cysteines proximal to acid, alkaline and aromatic residues in protein consensus
motifs as being the most susceptible to S-nitrosylation183. The reactivity of NO signaling
molecules like other RSNOs, HNO2 and other NO+ to these consensus motifs is another
important

factor

that

determines

whether

protein

thiols

are

S-nitrosylated.

Transnitrosylation reactions between peptide RSNOs and peptide thiols are further
complicated by variable cysteine residue pKa, changes in peptide conformations and
cellular redox environments 141, 184-185 186. The protonation of NO2- to HNO2 is favored in
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acidic conditions that are found in lysosomes, protein membrane microdomains and
mitochondria intermembrane spaces

187

. In these acidic solutions, HNO2 exists

predominantly as HONO which can be further protonated to form the nitrosonium ion
(NO+) as depicted by Eq 3.2.

𝐻𝑁𝑂2 + 𝐻 + ⥨ 𝑁𝑂 + + 𝐻2 𝑂

𝐸𝑞 3.2

High acidity coupled with reduced water activity favor the formation of NO+. Snitrosylation of AVP by HNO2 was studied by generating HNO2 in situ through the reaction
between NaNO2 and HClO4. A typical UV spectrum of reactants was obtained, which
shows HNO2 (Fig 3.2a) and NaNO2 (Fig 3.2b) both having a significant absorbance at 355
nm, with absorptivity coefficient of 22.9 M-1cm-1. The vasopressin S-nitrosothiol [AVP(SNO)] absorbs at both 335 nm and 545 nm (Fig 3.2c), with molar absorptivity coefficients
(Ƹ) of 922 M-1cm-1 and 16 M-1cm-1 respectively. With this data, which was in good
agreement with other Ƹ545 values reported for RSNOs 188-190, we determined that each AVP(SNO) group’s molar absorptivity coefficient at 545 nm would be 16 M-1 cm-1. We
followed AVP-(SNO) production at 545 nm as that region was devoid of any interference.
At 280 nm peptides with tryptophan (Trp), cysteine and tyrosine (Tyr) amino acid residues
exhibit significant absorptivities191.
Since the absorption of these amino acids at 280 nm is additive, the extinction coefficient
of the whole peptide can be determined. Figure 3.2d shows 0.17 mM AVP disulfide
[AVP(S-S)] with a molar absorptivity coefficient, Ƹ280 =1615 M-1cm-1. The total AVP(SS) Ƹ280 was a result of individual contributions of 125 M-1cm-1 and 1490 M-1cm-1 from
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cystine and tyrosine residues respectively192. In Figure 3.2e; 0.17 mM AVP dithiol
[AVP(S-H)] had Ƹ280 =1490 M-1cm-1 which only accounts for the molar absorptivity from
the tyrosine residue. HPLC-UV-MS was employed for monitoring AVP S-nitrosylation
reactions, and two distinct products were identified. HPLC-UV chromatograms (Fig 3.3A)
show the reaction between nitrous acid and AVP dithiol where [HNO2]0 >> [AVP(SH)]0,
such that AVP(SH) was the limiting reagent. Two species were identified as shown by peak
1 eluted at 13.5 mins and peak 2 eluted at 15 mins. Mass spectrometry (Fig 3.3B) identified
peak 1 as doubly protonated (M+2H)2+ (m/z 558.76) singly S-nitrosylated AVP
[AVP(SNO)]. Whilst peak 2 was identified as doubly protonated (M+2H)2+ (m/z 572.72)
doubly S-nitrosylated AVP [AVP(SNO)2]. Even though our product contains a mixture of
both AVP(SNO) and AVP(SNO)2, the latter had the highest relative abundance and was
the dominant product under our established reaction conditions.

3.2.2.1 Effect of AVP(SH) variation. Our stopped-flow setup involved mixing AVP(SH),
H+ and NaClO4 (for maintaining ionic strength) in feeding stream one, whilst the second
feeding stream contained NaNO2. The injection of H+ and NaNO2 in separate feeding
streams allowed for the generation of HNO2 in-situ and obviated the possibility of HNO2
decomposition before S-nitrosylation could commence. Figure 3.4A, depicts the effects of
[AVP(SH)] variation at constant [H+] and [NO2-]. Plots of initial rate vs [AVP(SH)] were
linear with an intercept kinetically indistinguishable from zero (Fig 3.4B). The reaction
shows first order dependence in [AVP(SH)] for a broad range of AVP(SH) concentrations
where [NO2-]0 and [H+]0 > [AVP(SH)]0.
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Figure 3.2: Spectra scan of; (a) [HNO2-] = 3.5 mM, (b) [NO2-] = 4 mM, (c) [AVP] = 1 mM,
[NO2-] = 10 mM and [H+] = 50 mM, (d) [AVP(S-S)] = 0.17 mM and (e) AVP(SH) = 0.17 mM
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Figure 3.3: HPLC-UV-MS analysis of the reaction between 5 mM AVP thiol and 20 mM nitrous
acid. HPLC chromatogram; (A) shows the elution times of two species; peak 1 at 13.5 mins and
peak 2 at 15 mins. ESI mass spectra (B), identifies compounds eluted in peak 1 as singly Snitrosylated AVP(SNO) and peak 2 doubly S-nitrosylated AVP(SNO)2.
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Figure 3.4: (A) Effect of [AVP(SH)] variation on AVP(SNO) formation at 25 °C. Fixed [H+] = 1
mM, [EDTA] = 100 µM, [NO2-] = 1 mM. Varied [AVP(SH)] = (a) 200 µM, (b) 300 µM, (c) 400
µM, (d) 500 µM, (e) 600 µM, (f) 700 µM. (B) Initial rate plot shows strong dependence of
AVP(SNO) formation on AVP(SH) concentration.
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Figure 3.5: (A) Effect of [NO2-] variation on AVP(SNO) formation at 25 °C. Fixed [H+] = 1 mM, [EDTA]
= 100 µM, [AVP] = 1 mM. Varied [NO2-] = (a) 300 µM, (b) 400 µM, (c) 500 µM, (d) 600 µM, (e) 700 µM.
(B) Initial rate plot shows strong dependence of AVP(SNO) formation on NO2- concentration.

3.2.2.2 Effect of nitrite variation. Nitrite variation gave simple and first order kinetics (Fig
3.5A), when initial nitrite concentrations ([NO2-]0) remained below [H+]0, therefore all
reactive nitrogen species (RNS) where in the form of protonated HNO2. The amount of
AVP(SNO) formed increased until [NO2-]0 exceeded [AVP(SH)]0 resulting in saturation.
Plots of initial rate vs [NO2-]0 were also linear with a zero intercept (Fig 3.5B).
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3.2.2.3 Effect of acid variation. The effects of H+ variation were complex and largely
dependent on the ratio of [H+]0: [NO2-]0. The rate of AVP(SNO) formation was especially
dependent on whether [H+]0 exceeded [NO2-]0. Figure 3.6A, traces (a-c) depict AVP(SNO)
formation in low [H+]0 conditions where [H+]0 < [NO2-]0, and the rate of AVP(SNO)
formation is 1st order with respect to [H+]0. Interestingly, when [H+]0 ≥ [NO2-]0 as shown
in Figure 3.6A, traces (a-c)), still resulted in an increase in the rate of AVP(SNO) formation
despite a saturation with regards to [HNO2] in the reaction solution. A plot of initial rate
vs [H+]0 was linear with a non-zero intercept with points to another nitrosating agent after
the amount of HNO2 saturates (Fig 3.6B).

3.2.2.4 Effect of Cu2+ variation. Our data suggest a catalytic role for Cu2+ ions in
AVP(SNO) formation. Figure 3.7A depicts the effect of Cu2+ on reactant concentrations
from Figure 3.5A, trace (e) which were run with no added [H+] and in the absence of metal
chelator EDTA. Clearly Cu2+ ions are effective catalysts of AVP(SNO) formation even in
micromolar concentrations. A rate plot of Cu2+ ions’ catalyst effect on AVP(SNO)
formation (Fig 3.7B) depicts a linear relationship between [Cu2+] and the rate of
AVP(SNO) formation with initial rates an order of magnitude higher than acid catalyzed
reactions (Fig 3.5B). The non-zero y-intercept represents the nitrosating effect of NO2- in
the absence of H+ and Cu2+. Interestingly, a closer comparison of the final absorbance
values of Fig 3.5A, trace (e) and the highest absorbance attained by Fig 3.7A, trace (f);
0.008 vs 0.005, points to another reaction mechanism in which Cu2+ ions would also
catalyze the decomposition of AVP(SNO) thus affecting the maximum amount of
AVP(SNO) detected.

There are competitive kinetics involved in both AVP(SNO)
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formation and depletion due to redox cycling that occurs between Cu2+ and Cu+ ions as
shown by R3.1 and R3.2:

2𝐴𝑉𝑃(𝑆 − ) + 2𝐶𝑢2+ → 2𝐴𝑉𝑃(𝑆 − 𝑆) + 2𝐶𝑢+

𝑅3.1

2𝐴𝑉𝑃(𝑆𝑁𝑂) + 2𝐶𝑢+ → 2𝐴𝑉𝑃 + 2𝐶𝑢2+

𝑅3.2

Figure 3.6: (A) Effect of [H+] variation on AVP(SNO) formation at 25 °C. Fixed [NO2-] = 1 mM,
[EDTA] = 100 µM, [AVP] = 1 mM. Varied [H+] = (a) 400 µM, (b) 600 µM, (c) 800 µM, (d) 1 mM,
(e) 1.1 mM, (f) 1.2 mM. (B) A plot of initial rates vs [H+]0 was linear with a non-zero intercept.
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Figure 3.7: (A) Effect of [Cu2+] variation on AVP(SNO) production at 25 °C. The rate of
AVP(SNO) production increases as [Cu2+] increases. Fixed [NO2-] = 700µM, [AVP] = 1 mM, [H+]
= 0.00 M. Varied [Cu2+] = (a) 50 µM, (b) 100 µM, (c) 150 µM, (d) 200 µM, (e) 250 µM, (f) 300
µM. (B) A plot of initial rate vs [Cu2+] was linear with a non-zero intercept.
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3.2.2.5 Nitrous acid kinetic reaction scheme. The dynamics of this bimolecular reaction
suggests 4 reactions as being essential in HNO2-mediated S-nitrosylation of AVP thiol.
Reaction 3.3, involves protonation of NO2- to produce HNO2, this followed nitrosyl cation
(NO+) production in excess acid (R3.4) and the reactions of both HNO2 and NO+ with
AVP(SH).

Based on AVP(SNO) formation the rate of reaction is given by equation 3.3:

𝑑[𝐴𝑉𝑃(𝑆𝑁𝑂)]
𝑑𝑡

= 𝑘3 [𝐴𝑉𝑃(𝑆𝐻)][𝐻𝑁𝑂2 ] + 𝑘4 [𝐴𝑉𝑃(𝑆𝐻)][𝑁𝑂+ ] − 𝑘−4 [𝐴𝑉𝑃(𝑆𝑁𝑂)][𝐻 + ] Eq 3.3

Before accumulation of AVP(SNO), the terminal term in Eq 3.3 is irrelevant. All reactive
nitrogen species ([RNST]) in solution adhere to the mass balance equation 3.4:

[𝑅𝑁𝑆𝑇 ] = [𝑁𝑂2− ] + [𝐻𝑁𝑂2 ] + [𝐴𝑉𝑃(𝑆𝑁𝑂)] + [𝑁𝑂 + ]

Eq 3.4

The sole source of [RNS]T in the reaction mixture is NO2-. The cation NO+ is essentially
a reactive intermediate, that is relevant in excess acid. A steady-state approximation is
applied on the NO+, as this allows us to estimate NO+ concentrations (Eq 3.5).
43

[𝑁𝑂+ ] =

𝑘2 [𝐻𝑁𝑂2 ][𝐻 + ]
𝑘−2 +𝑘4 [𝐴𝑉𝑃(𝑆𝐻)]

Eq 3.5

Employing the dissociation constant of HNO2 and Eq 3.5, we obtained an initial rate law
(Eq 3.6) that accounts for the complex effect of H+ concentrations.

𝑑[𝐴𝑉𝑃(𝑆𝑁𝑂)
𝑑𝑡

=

[𝐴𝑉𝑃(𝑆𝐻)][𝑅𝑁𝑆𝑇 ][𝐻 + ]
𝐾𝑎

+[𝐻 + ]

[𝑘3 + 𝑘

𝑘2 𝑘4 [𝐻 + ]
]
−2 +𝑘4 [𝐴𝑉𝑃(𝑆𝐻)]

Eq 3.6

Kinetic data from Figures 3.4 – 3.6 conforms to the parameters outlined by Eq 3.6. Our
initial rate law predicts 1st order kinetics in H+ (at low acid), AVP(SH) and NO2concentrations without saturation. At low [H+]0 the second term in Eq 3.6 would be
negligible, therefore kinetic runs retain first-order kinetics in accordance with first term.
When [H+]0

≥

[NO2-]0, there is saturation with regards to HNO2 concentrations.

Interestingly, traces (e)-(f) in Fig 3.6A depict a continuous increase in initial rate despite
HNO2 saturation which implicates another nitrosating agent formed in excess [H+]
according to reaction R3.7.

Considering both nitrosating agents (HNO2/NO+) gives an overall rate of reaction governed
by Eq 3.7:

𝑑[𝐴𝑉𝑃(𝑆𝑁𝑂)]
𝑑𝑡

={

[𝐻 + ][𝑅𝑁𝑆𝑇 ]
} [𝐴𝑉𝑃(𝑆𝐻)][𝑘3
[𝐻 + ]+𝐾𝑎

+ 𝑘4 𝐾𝑏 [𝐻 + ]]
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Eq 3.7

The bimolecular rate constants for HNO2/NO+ mediated S-nitrosylation of AVP(SH) are
represented by k3 and k4 respectively in Eq 3.7. In subsequent calculations, we used the Ka
of HNO2 (5.62x10-4 M-1) and Kb (1.2 x 10-8 M-1s-1) from reaction R3.7. At high [H+], a plot
of initial rate/[RNST][AVP(SH)] vs. [H+] is linear with a slope (k4Kb) and intercept (k3)
(Fig 3.6 and Eq 3.7). Using Eq 3.7 and kinetic data from Fig 3.6, we determined our k3 to
be 278 ± 10 M-1s-1 and k4 as 2.24 x103 M-1s-1. These studies show that AVP(SNO)
formation is through the direct reaction of HNO2 with AVP(SH), with NO+ as the major
nitrosating agent in high acidic media.

3.2.2.6 Temperature dependence and thermodynamic analysis. An essential component
of kinetic data is that it does not only elucidate reaction dynamics but also provides an indepth comprehension of thermodynamic parameters. In this study, we employ transient
state kinetics to elucidate the dynamics of HNO2 mediated AVP thiol S-nitrosylation
reactions. Transient state kinetics allow for the determination of observed rate constant
(kobs) based on an approach that compares reactant concentrations with the time scale
required for the reaction to attain a state of equilibrium. Therefore, kobs values are
fundamentally distinct from bimolecular rate constants. Pseudo-1st-order kinetics would
be obtained for the rate of a reaction (R3.6) approaching equilibrium [equilibrium constant
(K) = kon/koff], if an overwhelming excess of HNO2/NO+ was used in AVP S-nitrosylation
thus resulting in kobs values that are function of [NO+] (Eq 3.8). Linear plots of kobs vs
[NO+] would allow for the determination of kon and koff from the slope and intercept,
respectively.
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To mitigate extrapolation errors which are usually prevalent in evaluating slope and
intercept values, all reported kon and koff values in this study are obtained from an average
of 5 kinetic experiments and standard deviation is used for all uncertainty estimates.

𝑘𝑜𝑏𝑠 = 𝑘𝑜𝑛 [𝑁𝑂+ ] + 𝑘𝑜𝑓𝑓

Eq 3.8

The natural log of kobs was then plotted against the inverse of temperature in kelvins. The
linear fitting function in SigmaPlot 14 and the Arrhenius equation (Eq 3.9) were used to
calculate the activation energy (Ea). In Eq 3.9; A is the Arrhenius pre-exponential factor;
T is temperature in kelvins and R is the gas constant (8.314472 J mol-1 K-1). Erying plots
[ln(k/T) against 1/T] were used to evaluate activation enthalpies (∆H‡) and entropies (∆S‡)
according to the eyring equation (Eq 3.10). Gibbs free energy of activation (∆G‡) values
were determined at 37 °C according to Eq 3.11. In Eq 3.11, h is Planck’s constant (6.626
x 10-34 J.s-1), R and T are temperature (kelvins) and R is the gas constant respectively and
kB is the Boltzmann constant (1.3806504 x 10-23 J-1K-1).

ln 𝑘𝑜𝑏𝑠 = ln 𝐴 −
𝑘

ln (𝑇) = −

∆H‡
𝑅𝑇

∆G ‡ = 𝑅𝑇 [

+

𝐸𝑎
𝑅𝑇

∆S‡
R

𝑙𝑛(𝑘𝐵 𝑇)
ℎ

Eq 3.9
𝑘

+ ln ( h𝐵 )

Eq 3. 10

− ln 𝑘𝑜𝑏𝑠 ]

Eq 3. 11

We ran traces in Fig 3.6 in pseudo-1st-order conditions with at least 10-fold excess of
HNO2 (10-55 mM) in temperatures ranging from 15-35 °C as depicted by Fig 3.8A.
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Observed rate constants from these kinetic runs (Table 3.2) show S-nitrosylation rates that
increase ~2.7-fold with each 10 °C increment in temperature with stopped-flow spectra
that was highly analogous exhibiting characteristics of typical pseudo-1st-order reactions.
Erying plots (Fig 3.8B) and the Eyring equation (Eq 3.10) utilized observed kon and koff
values from Table 3.2 to determine the following thermodynamic parameters; for kon as Ea
= 35.7 kJmol-1; ∆H‡on = 33.3 ± 2 kJ mol-1 and ∆S‡on = -1± 0.06 J mol-1 K-1; and for koff as
Ea = 43.0 kJmol-1; ∆H‡off = 41.06 ± 4 kJ mol-1 and ∆S‡off = 1.5 ± 0.2 J mol-1 K-1) (Table
3.3). Activation parameters ∆G‡ and ∆H‡ for HNO2/NO+ mediated AVP(SNO) formation
suggest an endergonic and endothermic reaction for both kon and koff. The negative ∆S‡ for
kon implicates an associative mechanism with an unstable transition state. As expected, the
positive ∆S‡ for koff describes a dissociative mechanism as would be the case for
AVP(SNO) decomposition. As previously noted, our calculated ∆S‡ and ∆H‡ values are
derived kinetic runs where kobs parameters are determined by extrapolation from slope and
intercept values. Given that our stopped-flow instrument has a reaction dead time of 2
milliseconds, one could rightfully question whether using other more sensitive methods
would produce different ∆H‡ and ∆S‡ values. Laser flash photolysis is a nanosecond (ns)
time-resolved spectroscopic technique that is used to probe sample excitation levels with a
laser beam 193. This technique has garnered much interest among biochemists working to
explore various protein metastable states and dynamics.
A study comparing semi-independent kinetic data from various laboratories investigating
metmyoglobin and NO interactions using both stopped flow and flash photolysis found that
∆H‡ values had statistically insignificant differences that where with a margin of error 194.
Extraction of these essential thermodynamic parameters provides an in-depth
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understanding of elementary reaction mechanisms involved in nitrosation and
denitrosation process.

Figure 3.8: (A) Observed rate constants for the S-nitrosylation of AVP(SH) by varied NO+ concentrations
over a broad temperature range of 15-35 °C. Fixed [EDTA] = 100 µM, [AVP] = 1 mM. Varied [H+] and
[NO2-] from 10-55 mM (B) Linear Erying plots determining activation parameters H‡ and ΔS‡ measured by
stopped-flow spectroscopy.
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Table 3.2: Observed rate constants for NO+ mediated AVP thiol S-nitrosylation reactions.
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
0.70 ± 0.03
1.45 ± 0.05
2.35 ± 0.14
3.57 ± 0.15
4.74 ± 0.09

koff (s-1)
9.61 ± 1.1
52.98 ± 1.70
88.17 ± 3.31
111.71 ± 5.86
217.54 ± 3

Table 3.3: Thermodynamic parameters for NO+ mediated AVP thiol S-nitrosylation
reactions.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

35.7

33.6

33.3

-1.0

43.0

41.06

40.6

1.5

kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature = 37oCb

3.2.2.7 EPR analysis. Figure 3.9 shows a series of EPR spectra which depicts the
involvement of NO in AVP(SNO) decomposition. Spectra are similar to those reported
with nitroethane-NO trap195. A mixture of a nitroethane trap (forms adduct with NO.) and
AVP(SH) does not show any signal (Fig 3.9A), whilst spectra taken 20s (Fig 3.9B) and 30s
(Fig 3.9C) after NO2- addition depict an increase in EPR signal with time. The broad signal
in Fig 3.9A may be due to some cavity contamination, however spectra B through G appear
to ride over this spectral feature. To evaluate the effect of Cu2+ on AVP(SNO)
decomposition, we ran EPR spectra on Fig 3.7A traces (a)-(c) in the presence of a
nitroethane trap (Figs 3.9D-3.9F). We observed an increase in signal with increase in [Cu+]
in spectra taken 5s after the addition of Cu+. Our data confirms copper redox cycling as
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depicted by R3.1 and R3.2.

Figure 3.9: EPR spectra of NO. generation during AVP(SNO) decomposition using 0.5 M nitroethane spin
trap. (A) [nitroethane]= 0.5M, [AVP(SH)] = 1 mM. (B) [nitroethane]= 0.5M, [AVP(SH)]= 1 mM, [NO2-]=
700µM and [H+]= 1 mM after 20s. (C) [nitroethane]= 0.5M, [AVP(SH)]= 1 mM, [NO2-]= 700µM and [H+]=
1 mM after 30s. (D-F) Spectra taken after 5s with fixed [nitroethane]= 0.5M, [AVP(SH)]= 1 mM, [NO2-]=
700µM. Varied [Cu+] = (D) 50 µM, (E) 100 µM, (F) 150 µM.

3.2.3 Peroxynitrite mediated AVP(SH) S-nitrosylation. The kinetics of oxidation and Snitrosylation of AVP(SH) by ONOO- were monitored by tracking AVP(SNO) formation
and ONOO- depletion at 545 nm and 302 nm (Ƹ = 1670 M−1cm−1) respectively (Fig 3.9).
The reactivity of ONOO- (pKa 6.8) is multifaceted, extremely pH-dependent and ONOOis highly unstable in acidic media as it spontaneously disintegrates with a half-life less than
a second at physiological pH and temperature196. At pH 1.0, NO3- is the main product of
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ONOO- decomposition with an absorption peak 302 nm, which complicates ONOOdepletion experiments in highly acidic medium (R3.10)197. At physiological pH both
ONOO- /ONOOH co-exist, with NO2- and O2 as major decomposition products (R3.11), as
is the case at pH >8.0 (R3.12).

Figure 3.9: Spectra scan of; (a) [AVP(SH)] = 150 µM, (b) [ONOO-] = 300 µM, (c) AVP(SNO) formation
from reaction mixture with; [AVP(SH)] = 1.5 mM, [ONOO-] = 1.5 mM in PBS at pH 7.4.

Subsequent kinetic analysis was conducted at pH 7.4 in 0.1M PBS buffer and also in mildly
acidic media.
𝑂𝑁𝑂𝑂𝐻 → 𝑁𝑂3− + 𝐻 +

𝑅 3.10

𝑂𝑁𝑂𝑂𝐻 + 𝑂𝑁𝑂𝑂− → 2𝑁𝑂2− + 𝑂2 + 𝐻 +

𝑅 3.11

2𝑂𝑁𝑂𝑂− → 2𝑁𝑂2− + 𝑂2

𝑅 3.12
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3.2.3.1 Effect of AVP(SH) variation on ONOO- depletion and AVP(SNO) formation. By
varying concentrations of AVP(SH) we probed the role of AVP(SH) in ONOO- depletion
while [ONOO-] was held constant (Fig 3.10A). All ONOO- oxidations at pH 7.4 show fast
autocatalytic decomposition kinetics. Increments in [AVP(SH)] gave higher ONOOdepletion rates and we determined the bimolecular rate constant for the direct Snitrosylation of AVP(SH) by ONOO- to be 884 ± 31 M-1 s -1 from spectra depicted in Figure
3.10B. The non-zero y-intercept (1 x10-4 Ms-1) represents the rate of ONOOdecomposition under our reaction conditions in the absence of AVP(SH). For [ONOO-]0:
[AVP(SH)]0 ratios utilized in our kinetic runs, an evaluation of AVP(SNO) formation at
pH 7.4 showed 1st-order dependence of AVP(SNO) formation on [AVP(SH)] (Fig 3.1°C
and D). The reaction kinetics were also similar when [ONOO-] is in overwhelming excess
over AVP(SH) concentrations (data not shown).

3.2.3.2 Effect of acid variation on ONOOH mediated S-nitrosylation. Kinetics of
AVP(SNO) formation by ONOO- showed a complex dependence on acid concentrations as
illustrated by R3.10. The effect of adding acid when [H+] < ONOO- is shown Figure 3.11.
The data shows the catalytic effect of acid on AVP(SNO) formation, as an increase in [H+]
increases the rate of AVP(SNO) formation until [AVP(SH)] becomes limiting and
saturation sets in. Increments in [H+] did not reduce the amount of AVP(SNO) formed, this
suggests that rates of AVP(SNO) formation do not need to be faster than the rate of ONOOdecomposition due to the formation of ONOOH as the major nitrosating agent. As
expected, the rate of ONOO- depletion by AVP(SH) is also highly dependent on acid
concentrations. Holding [AVP(SH)] and [ONOO-] constant while varying [H+] where
52

[AVP(SH)] < [ONOO-] (Fig 3.12A), shows rates of ONOO- depletion by AVP(SH) that
are proportional to increases in acid concentration with nonlinear curved rate plots with
respect to [H+] (Fig 3.12B). Using experimental data from Figures 3.11 and 3.12, we
determined the bimolecular rate constant for the direct S-nitrosylation of AVP(SH) by
ONOOH to be 1.72 x 104 M-1s-1 at 25oC.

3.2.3.3 Effect of peroxynitrite variation and EPR analysis. Variation of ONOO- at pH7.4
to determine its effect on AVP(SNO) formation shows a steady increase in the rate of
AVP(SNO) formation with increments in [ONOO-] (Fig 3.13A). The reaction is rapid
without an induction period. Rate plots depict 1-st order kinetics with regards to [ONOO-]
(Fig 3.13B). Addition of micromolar Cu2+ concentrations in both mildly acidic and pH7.4
ONOO- mediated reactions, reproduced the catalyst effect of Cu2+ on AVP(SNO)
formation rates as shown in Figure 3.7. As expected, addition of NO2- on traces in Figure
3.10 resulted in increased AVP(SNO) absorbance values due to the formation of HNO2.
The same but smaller effect was observed when NO2- was added to traces in Fig 3.13, due
to the limited nitrosating power of NO2- in the absence of acid. It is generally accepted that
decomposition of ONOOH/ONOO- yields NO2- and O2 under widely varying reaction
conditions (Scheme 3.1), and kinetic predictive models have been developed based on the
evidence that the decomposition reaction forms NO2, •NO and •O2- and •OH radical
intermediates198. For CO2- catalyzed ONOOH/ONOO- decomposition, formation of
nitrogen dioxide and carbonate radicals from the nitrosoperoxycarbonate anion is a feasible
unimolecular activation step199-200. A current area of intense research is aimed at
determining if rates of ONOOH/ONOO- decomposition agree with the thermodynamics of
53

O-O bond homolysis to form nitrogen dioxide and hydroxide radicals.

Figure 3.10: Effect of varying AVP(SH) concentrations on ONOO- depletion in PBS at pH 7.4. Fixed
[EDTA] = 100 µM, [ONOO-] = 1 mM. (A) Varied [AVP(SH)] = (a) 300 µM, (b) 400 µM, (c) 500 µM, (d)
600 µM, (e) 700 µM. (B) Shows linear relationship between initial rates of ONOO- depletion and AVP(SH)
concentrations for traces in (A). Effect of varying AVP(SH) concentrations on AVP(SNO) formation in PBS
at pH 7.4. (C) Varied [AVP(SH)] = (a) 300 µM, (b) 400 µM, (c) 500 µM, (d) 600 µM, (e) 700 µM. (D)
Shows linear relationship between initial rates of AVP(SNO) and AVP(SH) concentrations for traces in (C).
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Figure 3.11: (A) Effect of varying H+ concentrations on ONOO- mediated AVP(SNO) formation. Fixed
[AVP(SH)] = 1 mM, [EDTA] = 100 µM, [ONOO-] = 1 mM. Varied [H+] = (a) 100 µM, (b) 150 µM, (c) 200
µM, (d) 250 µM, (e) 300 µM. (B) Linear relationship between initial rates of AVP(SNO) and H+
concentrations for traces in (A)

Figure 3.12: (A) Effect of varying H+ concentrations on ONOO- depletion. Fixed [AVP(SH)] = 700 µM,
[EDTA] = 100 µM, [ONOO-] = 1 mM. Varied [H+] = (a) 200 µM, (b) 250 µM, (c) 300 µM, (d) 350 µM, (e)
400 µM, (f) 450 µM. (B) Initial rates plot shows an exponential increase in ONOO- depletion with
increased acid concentrations.
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Figure 3.13: Effect of varying ONOO- concentrations on AVP(SNO) formation in PBS at pH 7.4. Fixed
[EDTA] = 100 µM, [AVP(SH)] = 1 mM. (A) Varied [ONOO-] = (a) 200 µM, (b) 300 µM, (c) 400 µM, (d)
500 µM, (e) 600 µM. (B) Shows linear relationship between initial rates of AVP(SNO) formation and
ONOO-concentrations for traces in (A).

To identify oxidizing intermediates, we conducted EPR analysis at pH7.4 where both
ONOOH/ONOO- species are known to exist. EPR spectra obtained in Figure 3.14 shows
DMPO (spin trap) radical adduct of ONOOH mediated AVP(SH) S-nitrosylation in mildly
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acidic media. The Fenton's reaction (R3.13 - R3.16) which is known to generate •OH, was
used as a standard to monitor hydroxyl radical production (Fig 3.14A). This trace shows
the 1:2:2:1 quartet spectrum with splitting of aN = aH = 14.9 G which is characteristic of
DMPO-OH radical adduct201.

Scheme 3.1: O2 and NO2- production during ONOO- decomposition
𝐹𝑒 2+ + 𝐻2 𝑂2 → 𝐹𝑒 3+ + 𝑂𝐻 . + 𝑂𝐻 −

𝑅 3.13

𝑂𝐻 . + 𝐻2 𝑂2 → 𝑂𝑂𝐻 . + 𝐻2 𝑂

𝑅 3.14

𝑂𝑂𝐻 . + 𝐻2 𝑂 ↔ 𝑂2− + 𝐻3 𝑂+

𝑅 3.15

𝐷𝑀𝑃𝑂 + 𝑂𝐻 . → 𝐷𝑀𝑃𝑂 − 𝑂𝐻 (𝐸𝑃𝑅 𝑎𝑐𝑡𝑖𝑣𝑒)

𝑅 3.16

Trace (B) in Fig 3.14 shows a mixture of DMPO and ONOO- without AVP(SH) with no
signal. Addition of increasing amount of AVP(SH) in traces (C)-(E) shows an increase in
DMPO-OH radical adduct formation depicted by a stronger signal intensity with a 1:2:2:1
quartet with splitting of aN = 15.4 G; aH = 16.2 G. Addition of mannitol (a well-known .OH
scavenger), resulted in total signal loss (Fig 3.14F), which is conclusive evidence of
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hydroxyl radical production during ONOO- mediated AVP(SNO) formation.

Figure 3.14: EPR spectra of DMPO radical adducts ONOO- mediated AVP(SNO) formation at pH
7.4. Spectra was collected immediately upon mixing reactants at room temperature. (A) Fenton’s
reaction; [H2O2] = 0.1M, [FeSO4] = 0.025M, [DMPO]= 50 mM. Spectra (B-F) had fixed [ONOO-] = 1 mM
and [DMPO]= 50 mM. (B) [AVP(SH)] = 0 M, (C) [AVP(SH)] = 300 µM. (D) [AVP(SH)] = 500 µM, (E)
[AVP(SH)] = 700 µM. (F) [AVP(SH)] = 700 µM and [Mannitol]= 1.5 mM

We also probed the formation of NO. by ONOO- reactions with AVP(SH) as an
intermediate during AVP(SNO) formation and decomposition using EPR and nitroethane
as a spin trap. The EPR spectra was similar to Fig 3.9 and that proves the release of NO
radicals upon decomposition of AVP(SNO). Our data is in agreement with earlier
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studies202-203 where injection of ONOO- into buffer solutions containing thiols within the
reaction vessel of a chemiluminescence analyzer also resulted in NO. production. Onset of
NO. formation was only detected after the reaction of ONOO- with AVP(SH) was complete
(after 10s). Since no NO. formation was detected prior to the addition to AVP(SH), our
data suggests that ONOO- decomposition itself at pH 7.4 does not produce NO. (Scheme
3.1) within the time scale of our experiments. Signal intensity of NO. production gradually
increased with time for over 2 min until no further change was observed. This suggests that
AVP(SNO) slowly decomposes to release NO., which would make it a good NO carrier
and donor. The reported stabilities of RSNOs varies widely, with primarily and secondary
RSNOs being commonly reported to be highly unstable, with half-lives of seconds to
minutes204.

3.2.3.4 Temperature dependence and thermodynamic parameters. Using methods
described in section 3.2.2.5. We ran traces from Figures 3.11 and 3.13 in pseudo-1st-order
conditions with at least 10-fold excess (10-55 mM) of ONOOH and ONOO- respectively
in temperatures ranging from 15-35 °C. The observed kobs rates for ONOOH mediated Snitrosylation spectral results were plotted against [ONOOH], with varied [ONOOH]
concentrations at each temperature (Fig 3.15A) and derived kobs values from Table 3.4. We
observed an approximately 2-fold increase in AVP(SNO) formation with every 10 °C rise
in temperature. These kobs rates were 2-orders of magnitude greater than those for
HNO2/NO+ mediated nitrosation reactions. The corresponding Eyring plots for kon and koff
are shown in Figures 3.15B and 3.15C respectively. The slope and intercept values were
used to calculate thermodynamic parameters; for kon as Ea = 24.9 kJmol-1 (Eq 9); ∆H‡on =
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42.6 kJ mol-1 and ∆S‡on = -53.7 J mol-1 K-1; for koff these are Ea = 34.8 kJmol-1; ∆H‡off =
33.3 kJ mol-1 and ∆S‡off = 62.1 J mol-1 K-1) (Table 3.5).

ONOOH is a more robust nitrosating agent than it’s conjugate base, as it is kinetically and
thermodynamically favorable as evidenced by the larger kobs values and Ea, ∆H‡ and ∆G‡
values. Data from kobs rates for ONOO- mediated S-nitrosylation reactions (Fig 3.16A) and
the derived kon and koff values (Table 3.6), shows a slow reaction with kobs rates at least 3orders of magnitude less than those for ONOOH.
Table 3.4: ONOOH mediated AVP thiol S-nitrosylation kon and koff values.
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
186 ± 18
242 ± 27
340 ± 36
465 ± 30
616 ± 51

koff (s-1)
10049 ± 561
10661 ± 918
14133 ± 886
17114 ± 1195
26815 ± 1627

Table 3.5: ONOOH mediated AVP thiol S-nitrosylation thermodynamic parameters.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

24.9

26.0

42.6

-53.7

34.8

16.8

33.3

62.1

kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature = 37oC b

With the following thermodynamic parameters; for kon as Ea = 75.4 kJmol-1; ∆H‡on = 77.2
kJ mol-1 and ∆S‡on = -13.8 J mol-1 K-1; and for koff as Ea = 44.8 kJmol-1; ∆H‡off = 42.3 kJ
mol-1 and ∆S‡off = 84.1 J mol-1 K-1) (Table 3.7). As established earlier, acid catalyzes
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AVP(SNO) formation. Therefore, we propose that the nitrosating agent HNO2, which is
produced as a result of ONOOH decomposition in acidic media (Scheme 3.1), adds to the
nitrosating power of ONOOH over its conjugate base.

Table 3.6. Observed rate constants for ONOO- mediated AVP thiol S-nitrosylation
reactions.
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
0.0882 ± 0.01
0.107 ± 0.01
0.112 ± 0.005
0.45 ± 0.04
0.56 ± 0.06

koff (s-1)
6.7 ± 0.2
11.04 ± 0.22
12.8 ± 0.12
19.5 ± 1.41
22.9 ± 1.9

Table 3.7. Thermodynamic parameters for ONOO- mediated AVP thiol S-nitrosylation
reactions.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

75.4

77.2

72.9

-13.8

44.8

67.4

42.3

81.4

kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature (T) = 37oC

61

Figure 3.15: (A) Observed rate constants for the S-nitrosylation of AVP(SH) by varied ONOOH
concentrations over a broad temperature range of 15-35 °C. Fixed [EDTA] = 100 µM, [AVP] = 1 mM. Varied
[ONOO-]: [H+] on a 1:1 ratio in the range 10-55 mM. (B) and (C) depict linear Erying plots from kon and koff
values that are stated in Table 3.4 respectively.
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Figure 3.16: (A) Observed rate constants for the S-nitrosylation of AVP(SH) by varied ONOOconcentrations over a broad temperature range of 15-35 °C in PBS at pH 7.4. Fixed [EDTA] = 100 µM,
[AVP] = 1 mM. Varied [ONOO-] in the range 10-55 mM. (B) and (C) depicts linear erying plots from kon
and koff values that are stated in Table 7.
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3.2.4 SNAP mediated transnitrosation. Transnitrosation is the transfer of NO from an Snitrosothiol to a thiol thus forming a new S-nitrosothiol species in the process (R3.17).
Transnitrosation is prevalent in vivo with reported outcomes ranging from altered protein
activity to the formation of S-nitrosothiol species that are effective NO carriers

205

. We

investigated AVP(SNO) formation through transnitrosation by SNAP. It’s been reported
that acid induces high rates of SNAP decomposition206, therefore transnitrosation reactions
were conducted only at pH 7.4 in 0.1M phosphate buffer.

𝑅𝑆𝑁𝑂 + 𝑅𝑆 ′ 𝐻 ↔ 𝑅𝑆 ′ 𝑁𝑂 + 𝑅𝑆𝐻

𝑅3.17

3.2.4.1 Effect of AVP(SH) and SNAP variation. The effect of AVP(SH) variation on
transnitrosation by SNAP is depicted in Figure 3.17A. Initial rate plots of AVP(SNO)
formation (Fig 3.17B) and SNAP decay (Fig 3.18) at 545 and 590 nm respectively, were
linear with 1st-order dependence in AVP(SH) concentrations. We also probed the effect of
SNAP variation on AVP(SNO) formation (Fig 3.19) and depletion of SNAP (Fig 3.20). As
anticipated, transnitrosation rates increased with increments in SNAP concentrations (Fig
3.19A) with linear rate plots depicting 1st-order dependence in SNAP concentrations for
AVP(SNO) formation and SNAP depletion (Fig 3.19B and Fig 3.20B) respectively. The
zero-intercepts on these rate plots, suggests that there are no other competing reactions with
regards to either AVP(SNO) formation or SNAP depletion besides the direct fiduciary
transnitrosation reaction.

64

From kinetic data in Figures 3.17-3.20, we derived Eq 3.12, which depicts the rate of SNAP
depletion as a function of [AVP(SH)] and we evaluated the bimolecular rate constant for
AVP(SH) S-nitrosylation by SNAP to be 233 ± 7 M-1 s -1.

−𝑑[𝑆𝑁𝐴𝑃] 𝑘𝑓 (𝐾𝐴𝑉𝑃(𝑆𝐻) [𝐴𝑉𝑃(𝑆𝐻)]𝑡 )
[𝑆𝑁𝐴𝑃]
=
𝑑𝑡
(𝐾𝐴𝑉𝑃(𝑆𝐻) + 𝐻 + )

𝐸𝑞 3.12

Figure 3.17: (A) Effect of varying AVP(SH) concentrations on SNAP mediated AVP(SNO) formation in
PBS at pH 7.4. Fixed [EDTA] = 100 µM, [SNAP] = 1 mM. (A) Varied [AVP(SH)] = (a) 100 µM, (b) 200
µM, (c) 300 µM, (d) 400 µM, (e) 500 µM, (f) 600 µM, (g) 700 µM. (B) Shows linear relationship between
initial rates of AVP(SNO) formation and AVP(SH) concentrations for traces in (A).
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Figure 3.18: (A) Effect of varying AVP(SH) concentrations on SNAP depletion in PBS at 590 nm and pH
7.4. Fixed [EDTA] = 100 µM, [SNAP] = 1 mM. (A) Varied [AVP(SH)] = (a) 200 µM, (c) 300 µM, (d) 400
µM, (e) 500 µM, (f) 600 µM. (B) Shows linear relationship between initial rates of SNAP depletion and
AVP(SH) concentrations for traces in (A).

Figure 3.19: (A) Varying SNAP concentrations and AVP(SNO) formation in PBS at pH 7.4. Fixed [EDTA]
= 100 µM, [AVP(SH)] = 1 mM. (A) Varied [SNAP] = (a) 200 µM, (b) 400 µM, (dc) 600 µM, (d) 800 µM,
(e) 1 mM. (B) Shows linear relationship between initial rates of AVP(SNO) formation and [SNAP]
concentrations for traces in (A).
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Figure 3.20: (A) Varying SNAP concentrations and SNAP depletion at 590 nm in pH 7.4 PBS. Fixed
[EDTA] = 100 µM, [AVP(SH)] = 400 µM. (A) Varied [SNAP] = (a) 600 µM, (c) 700 µM, (d) 800 µM, (e)
900 µM. (B) Rate plot depicts a linear relationship between SNAP depletion initial rates and AVP(SH)
concentrations for traces in (A).

The mechanism by which SNAP transfers it’s NO moiety to other thiols in vivo is still
disputed. An interaction between copper and thiols in the catalysis of NO transfer has been
implicated as a possible mechanism. Studies have shown that RSNO formation by protein
thiols in hemoglobin and calbindin requires copper (R3.18 – R3.20)207-208, and is inhibited
in the presence of copper chelators.
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Our results suggest that transfer of NO from RSNO to thiols is a direct process without the
formation of free NO as an intermediate209. Nucleophilic attack of the thiolate ion (RS-) on
the nitrogen atom of RSNO is proposed to be fast and facile under physiological conditions,
as well as being insensitive to copper and other transition metal ions (R3.21).

In this mechanism, the thiol pKa is critical factor. In peptides and proteins, the pKa values
of thiols vary greatly depending on their microenvironment, so some thiols may be more
susceptible to transnitrosation than others.

3.2.4.2 SNAP temperature dependence and thermodynamic parameters. Using methods
described in section 3.2.2.5 we ran traces from Fig 3.19 in excess SNAP (10-55 mM), the
observed kobs rates for SNAP mediated S-nitrosylation were plotted against [SNAP] at each
temperature (Fig 3.21A) and the derived kobs values stated in Table 3.8. We observed an
approximately 2-fold increase in AVP(SNO) formation with each 10 °C increment in
temperature. These kobs rates were 1 and 2-orders of magnitude greater than those for
HNO2/NO+ and ONOO- mediated nitrosation reactions respectively. In comparison to
ONOOH, they were an order of magnitude lower.
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Figure 3.21: (A) kobs values for AVP(SNO) formation obtained by varying temperature and SNAP
concentrations in pH 7.4 PBS. Fixed [EDTA] = 100 µM, [AVP] = 1 mM. Varied [SNAP] in the range 10-55
mM. B) and (C) depicts linear erying plots from kon and koff values that are stated in Table 3.8.
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The corresponding Eyring plots for kon and koff are shown in Figures 3.21B and 3.21C
respectively. Derived thermodynamic parameters were for kon are Ea = 30.7 kJmol-1; ∆H‡on
= 28.2 kJ mol-1 and ∆S‡on = -320 J mol-1 K-1; for koff are Ea = 35.1 kJmol-1; ∆H‡off = 32.6 kJ
mol-1 and ∆S‡off = -288.6 J mol-1 K-1) (Table 3.9). The highly negative activation entropy
suggests a rate-limiting transnitrosylation step comprising of an ordered associative
transition state (R3.21). These activation parameters suggest low energy barriers for
transnitrosylation under physiological conditions and support growing evidence that
transnitrosylation maybe a viable posttranslational mechanism for NO transport in vivo210.

Table 3.8: Observed rate constants for SNAP mediated AVP thiol S-nitrosylation reactions.
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
12.9 ± 0.4
14.5 ± 1.1
18.2 ± 1.6
22.5 ± 0.6
29.4 ± 2.1

koff (s-1)
157.8 ± 13.5
171.7 ± 37.3
292.30 ± 40
311 ± 28
384.1 ± 67.1

Table 3.9: thermodynamic parameters for SNAP mediated AVP thiol S-nitrosylation.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

30.7

21.5

28.2

-320.0

35.1

29.9

32.6

-288.6

kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature = 37oC b
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3.3 Conclusion. Our study evaluated the effects of pH, copper chelators and temperature
on the rate of AVP thiol autoxidation. We discovered that AVP thiols have half-lives
sufficient for subsequent S-nitrosylation reactions to occur. The temporarily reduction of
AVP(S-S) to AVP(SH) and the stability of AVP(SH) suggests a likelihood for novel
signaling mechanisms. Since thioredoxin (Trx) is known to increase the rate of NADPH
regeneration in vitro in the presence of the neurohypophysial peptide oxytocin, we propose
that Trx and similar proteins may produce AVP(SH) in vivo

211-212

. Even though high

cellular concentrations of glutathione would promote AVP(S-S) reformation there are still
several mechanisms within cells that could inhibit or slow down AVP(S-S) reformation.
The chemical modifications of AVP(S-S) to produce AVP(SH) and AVP(SNO) thus
promoting site-specific modulation of AVP functions. S-Nitrosylation of AVP(SH) gave
both singly and doubly S-nitrosylated AVP(SNO). Nitrous acid and nitrosonium mediated
AVP(SNO) formation were shown to be rapid in acidic media with low and positive
activation parameters for ΔG‡ and ΔH‡ for both kon and koff. Thermodynamic data suggests
an associative mechanism for kon and a dissociative mechanism for koff as shown by
negative and positive ΔS‡ values respectively. Kinetic and EPR analysis implicated copper
redox cycling between Cu2+ and Cu+ in catalyzing AVP(SNO) formation and
decomposition respectively. Therefore, we propose that AVP(SNO) formation and halflives in vivo would be largely dependent on cellular concentrations of copper ions and
possibly other transition metal ions. The reactions of AVP(SH) and ONOO-/ONOOH
showed a complex dependence of acid concentrations with lower bimolecular rates at
physiological pH. Our data suggests that ONOOH is a more robust nitrosating agent than
it’s conjugate base with higher bimolecular rate constants and lower activation energy. We
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propose that ONOO-/ONOOH mediated AVP(SNO) formation might be a potential
peroxynitrite detoxifying pathway. EPR analysis revealed hydroxyl radical production in
thiol reactions with ONOO-/ONOOH and NO radical release during AVP(SNO)
decomposition. Hydroxyl radical production can lead to oxidative stress and radical
induced damage that has been linked to various disease pathologies213. The release of NO
during AVP(SNO) decomposition suggests a role as an NO carrier and donor. It is feasible
that AVP(SNO) could modify AVP receptors leading to modifications in major signaling
pathways. There is already evidence of reversible SNO mediated trans-S-nitrosylation of
free cysteines on G protein-coupled receptors, which can alter signaling pathways214-215.
Our results show that AVP(SH) trans-S-nitrosylation reactions are both kinetically and
thermodynamically favorable with highly negative activation entropies that are typical of
associative transition states. These activation parameters suggest low energy barriers for
transnitrosylation under physiological conditions and support growing evidence that
transnitrosylation maybe a viable post-translational mechanism for NO transport in vivo.
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CHAPTER 4: KINETICS AND ENERGETICS OF S-NITROSOSOMATOSTATIN FORMATION
4.1 INTRODUCTION.
Somatostatin (SST) is a neuropeptide that inhibits the release of various hypothalamic
hormones and coordinates regulatory activities with inhibitory neurotransmitter gammaaminobutyric acid (GABA) in the CNS 216 217. The SST gene expresses two active forms;
somatostatin-14 (SST-14) which has 14 amino-acid residues and somatostatin-28 (SST28) that comprises of 28 amino-acid residues 218. Reports of NO production from neuronal
NOS and nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d) which are
both co-localized with SST in the CNS suggest the possibility of novel neurochemical
signaling mechanisms

219-220

. Stimulation of SST receptors in human retinal pigment

epithelial (RPE) cells is linked to elevated NO production which confers restorative effects
on damaged blood-retina barriers (BRB)221-222. SST thiol and disulfide exchange rates with
other abundant biological thiols like glutathione are rapid and there constant inter and intramolecular exchange reactions that often involve the formation of mixed disulfides 223.

Despite growing evidence of SST mediated regulation of NO and numerous reports of SST
thiol reactions with other biologically relevant thiols, little is known about NO-mediated
SST modifications. This chapter explores kinetic and thermodynamic parameters of SST14 thiol S-nitrosylation reactions.
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4.2 RESULTS AND DISCUSSION
4.2.1 SST-14 dithiol formation and stability. To establish whether the SST-14 thiol has
half-lives sufficient for subsequent S-nitrosylation reaction under physiologically relevant
conditions, SST-14 disulfide reduction was carried out using methods described in section
3.2.1. The extinction coefficients of SST-14 disulfide and thiol at 280 nm were determined
to be 5750 M-1cm-1 and 5500 M-1cm-1 respectively (Eq 4.1). Chromatogram (A) was a
standard sample of 35 µM SST-14 disulfide which was eluted at 1.87 mins (Fig. 4.1).
Chromatogram (B) shows the reaction product of incubating 10µM SST-14 disulfide for
30 minutes in 400 µM TCEP (40-fold excess), the product was eluted at 2.03 mins. Mass
spectrometry analysis of chromatogram (A), shows SST-14 disulfide with singly
protonated (M+H) + ions at m/z 1638.7 and the doubly protonated (M+2H)2+ ions at m/z
820.4 (Fig 4.2A). ESI-MS identified chromatogram (B) as singly protonated [(M+H) +]
thiol at m/z 1639.7 and the doubly protonated [(M+2H)2+] thiol at m/z 820.4 (Fig. 4.2B).

Ƹ280 = (# 𝑇𝑟𝑦𝑝𝑡𝑜𝑝ℎ𝑎𝑛 × 5500) + (# 𝐶𝑦𝑠𝑡𝑒𝑖𝑛𝑒 × 125)

𝐸𝑞 4.1

We then probed SST-14 thiol stability by monitoring the rate of SST-14 disulfide
reformation at varying temperatures, pH and in the presence of copper chelators using
HPLC chromatograms and equation 3.1.
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Figure 4.1: HPLC-UV analysis of SST-14 disulﬁde reduction. (A) A chromatogram of 35 µM SST14 disulfide was run as a standard, which was eluted at 1.87 mins. (B) 10µM AVP SST-14 thiol in
pH 3 water was incubated for 30 minutes in 400 µM TCEP (40-fold excess), the product was eluted
at 2.03 mins.

The time course reformation of SST-14 disulfide is summarized in Table 4.1. Our data
suggests that SST-14 thiol autoxidation occurs without a catalyst in acidic media. An
increase in temperature from 25-50 °C in acidic media markedly increased the rate of
autoxidation by 6-fold. Disulfide reformation rates also increased under mild oxidizing
conditions (pH 7.4), indicating the potential participation of the thiolate species in the
reaction. As expected, the introduction of copper chelators at pH 7.4 had a large inhibitory
effect on disulfide reformation. A comparison between AVP and SST-14 disulfide
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reformation rates highlights the difference in reactivities according to the peptide sequence,
hydrophobicity and electronic environment which determine access to thiol groups and
affects respective reaction rates 224. The half-life of SST-14 thiol at pH 7.4 and 37 °C was
determined to be 44 mins under physiological conditions.

Table 4.1. Effects of temperature, pH and copper chelators on time for SST-14 disulfide
reformation.

4.2.2 Nitrous acid mediated S-nitrosylation.
4.2.2.1 Effect of SST-14(SH) variation. A 1:1 ratio of [H+]0: [NO2-]0 was used to probe
the effects of SST-14(SH) concentrations on SST-14(SNO) rates formation. We observed
a linear increase in the rates of SST-14(SNO) formation with gradual increments in SST14(SH) concentrations (Fig 4.3A) for as long as suboptimal SST-14(SH) concentrations
were used. Rate plots in Figure 4.3B depicts 1st-order dependence of SST-14(SNO)
formation on [SST-14(SH)].
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Figure 4.2: ESI-MS analysis of HPLC chromatograms Fig 29. (A) ESI mass spectra confirmed
chromatogram A as SST-14 disulfide. (B) ESI mass spectra confirms chromatogram B as SST-14
thiol.
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Figure 4.3: 1st-order dependence SST-14(SNO) formation in SST-14(SH) concentrations. (A) Effect of
varying SST-14(SH) concentrations on SST-14(SNO) formation at 25 °C. Fixed [NO2-] = 1 mM, [EDTA] =
100 µM, [H+] = 1 mM. Varied [SST-14(SH)] = (a) 300 µM, (b) 400 µM, (c) 500 µM, (d) 600 µM, (e) 700
µM, (f) 800 µM. (B) Initial rate plots with respect to [SST-14(SH)]0 concentrations show a linear plot which
indicates a strong dependence of SST-14(SNO) formation on SST-14(SH) concentrations. ddd
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4.2.2.2 Effect of nitrite variation. Nitrite variation also gave is simple and 1st-order kinetics
(Fig 4.4) as long as [NO2-]0 do not exceed [H+]0, therefore all RNS where form of
protonated HNO2.

Figure 4.4: (A) Effect of varying [NO2-] concentrations on SST-14(SNO) formation at 25 °C. Fixed [SST14(SH)] = 1 mM, [EDTA] = 100 µM, [H+] = 1 mM. Varied [NO2-] = (a) 200 µM, (b) 300 µM, (c) 400 µM,
(d) 500 µM, (e) 600 µM, (f) 700 µM. (B) Rate plot shows 1-st order dependence of SST-14(SNO) formation
on [NO2-]0 concentrations.
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4.2.2.3 Effect of acid variation. Acid variation is complex (Fig 4.5). The data involves a
range of acid concentrations ranging from [H+]0 < [NO2-]0 to [H+]0 ≥ [NO2-]0. When [NO2]0 ≥ [H+]0, HNO2 concentrations are limited which results in slower rates of SST-14(SNO)
formation (Fig 4.5A, traces (a)-(d)). Traces (e)-(h) in Fig 4.5 show reaction conditions in
which [H+]0 > [NO2-]0 and
Fig 4.5B depicts the complex effect of acid variation as a sigmoidal curve which starts out
with a low slope that then increases to an inflection point ([H+]0 = 1 mM) before leveling
off as it approaches maximum rates of SST-14(SNO) formation. Since [NO2-]0
concentrations were constant, then constant [HNO2]0 is expected after the inflection point
and the effect of [H+]0 can be evaluated. The gradual but steady increase in rate of SST14(SNO) formation can only be attributed to NO+ as the major nitrosating agent (R3.4),
and a rate plot of traces (e)-(h) gives linear plot which suggests first order kinetics in high
[H+] with a non-zero y-intercept which gives an estimate of the S-nitrosylation effect of
HNO2 without excess H+ (Fig 4.5C). Using Eq 3.7 (section 3.2.2.4) and Fig 4.5, we
determined the bimolecular rate constants for SST-14 S-nitrosylation by HNO2 and NO+
to be 390 ± 56 M-1s-1 and 8.7 x104 M-1s-1.
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Figure 4.5: (A) Effect of [H+] variation SST-14(SNO) formation at 25 °C. Fixed [SST-14(SH)] = 1 mM,
[EDTA] = 100 µM, [NO2-] = 1 mM. Varied [H+] = (a) 200 µM, (b) 400 µM, (c) 600 µM, (d) 800 µM, (e) 1
mM, (f) 1.4 mM, (g) 1.7 mM, (h) 2 mM (B) Rate plots also show 1st-order dependence on H+ concentrations
(C) Effect of [H+] variation when [H+] ≥ 1 mM.
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4.2.2.4 NO+ S-nitrosylation temperature dependence and thermodynamic parameters.
Using methods described in section 3.2.2.5, traces in Fig 4.5 were ran large excess of HNO2
(10-55 mM). We observed kobs rates that were an order of magnitude greater in comparison
to those reported earlier in this work for HNO2/NO+ mediated AVP(SNO) formation, with
an ~1.5-fold increase in SST-14(SNO) formation rates (Table 4.2). The corresponding
Eyring plots for kon and koff are shown in Figures 4.6B and 4.6C respectively. The slope
and intercept values were used to calculate thermodynamic parameters; for kon and koff
(Table 4.3). Interestingly, the Gibbs free energy was identical to that obtained in NO+
mediated AVP(SNO) formation. Despite being kinetically more favorable SST-14(SNO)
formation, showed slight differences in ΔH‡ and ΔG‡ values with AVP(SNO).

Table 4.2. NO+ mediated SST-14 thiol S-nitrosylation kon and koff values
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
9.2 ± 0.6
10.6 ± 0.4
16.1 ± 1.1
16.8 ± 0.5
21.7 ± 0.8
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koff (s-1)
98.7 ± 18.9
108.9 ± 14.1
181.4 ± 27.6
207.3 ± 19.3
298.4 ± 25.9

Figure 4.6: (A) Observed rate constants for SST-14(SH) S-nitrosylation by HNO2 concentrations. Fixed
[EDTA] = 100 µM, [SST-14(SH)] = 1 mM. Varied [HNO2] in the range 10-55 mM. (B) and (C) depicts
linear erying plots from kon and koff values that are stated in Table 12 respectively.
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Table 4.3: NO+ mediated SST-14 thiol S-nitrosylation thermodynamic parameters.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

32.2

33.6

29.7

-12.7

42.1

43.0

40.0

9.68

kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature = 37oC b

4.2.3 Peroxynitrite mediated SST-14(SH) S-nitrosylation.
4.2.3.1 Effect of SST-14 variation. The rates of ONOO- depletion by SST-14(SH) are fast
with reaction completion times of ~15 s (Fig 4.8A). ONOO- depletion rates increase with
increasing SST-14(SH) concentrations. The initial rates plot of ONOO- depletion (Fig
4.8B) show 1st-order dependence in SST-14(SH) concentrations, whilst the effect of SST14(SH) on SST-14(SNO) formation showed a linear dependence without an induction
period (Fig 4.8C). Figure 4.8D shows a first-order dependence of SST-14(SNO) formation
on SST-14(SH) concentrations. We determined the bimolecular rate constant for the direct
S-nitrosylation of SST-14(SH) by ONOO- to be 308 ± 24 M-1s-1 at 25oC.
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Figure 4.8: Effect of varying SST-14(SH) concentrations on ONOO- depletion in pH 7.4 PBS at 302 nm.
Fixed [EDTA] = 100 µM, [ONOO-] = 1 mM. (A) Varied [SST-14(SH)] = (a) 400 µM, (b) 500 µM, (c) 600
µM, (d) 700 µM, (e) 800 µM. (B) Shows linear relationship between initial rates of ONOO - depletion and
SST-14(SH) concentrations for traces in (A). (C) Varied [SST-14(SH)] = (a) 200 µM, (b) 300 µM, (c) 400
µM, (d) 500 µM. (D) Shows linear relationship between initial rates of SST-14(SNO) and SST-14(SH)
concentrations for traces in (C).
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4.2.3.2 Effect of acid variation on ONOO- mediated SST-14(SNO) formation. Kinetics
of SST-14(SNO) formation through ONOOH mediated S-nitrosylation showed a complex
dependence on acid. At [H+] < [ONOO-], we observed the catalytic effect acid on SST14(SNO) formation (Fig 4.9A, traces (a)-(c)). However, increasing acid concentrations in
excess of ONOO-, did not result in further increase in SST-14(SNO) formation and actually
catalyzed it’s decomposition as depicted by a decrease in absorbance (Fig 4.9A, traces (d)(f)). Rate plots of [H+] were discontinuous as the first three H+ concentrations (Fig 4.9B,
(a)-(c)) showed reasonable linearity as a function of gradual increases in H+ concentrations,
which supports the conclusion that rates of SST-14(SNO) formation at low H+
concentrations have a 1st-order dependence on ONOOH concentrations. This linearity was
lost at higher acid concentrations (Fig 4.9B, (d)-(f)), therefore we anticipate a simple rate
law equations at low H+ concentrations and a complicated multi-term rate law at high H+
concentrations. Rates of SST-14 mediated ONOO- depletion were found to be directly
proportional to acid concentration (Fig 4.10A), with nonlinear curved rate plots as shown
in Fig 4.10B. Using the experimental data from Figures 4.9 and 4.10, we evaluated the
bimolecular rate constant for SST-14(SH) S-nitrosylation by ONOOH to be 1.55 x 103 M1 -1

s at 25oC.
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Figure 4.9: (A) Effect of varying H+ concentrations on ONOO- mediated S-nitrosylations in PBS at pH 7.4.
Fixed [SST-14(SH)] = 1 mM, [EDTA] = 100 µM, [ONOO-] = 1 mM. Varied [H+] = (a) 800 µM, (b) 900 µM,
(c) 1 mM, (d) 1.1 mM, (e) 1.2 mM, (f) 1.3 mM (B) Initial rate plot shows a direct relationship between

acid concentration and SST-14(SNO) formation, with a slowdown in SST-14(SNO) formation in
excess acid.

Figure 4.10: (A) Effect of [H+] variation on SST-14 depletion of ONOO-. Fixed [SST-14(SH)] = 600 µM,
[EDTA] = 100 µM, [ONOO-] = 1 mM. Varied [H+] = (a) 150 µM, (b) 200 µM, (c) 250 µM, (d) 300 µM, (e)
350 µM, (f) 400 µM. (B) Initial rates plot shows an exponential increase in ONOO- depletion with
increased acid concentrations.
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4.2.3.3 Peroxynitrite variation and EPR analysis. The reaction of SST-14(SH) and
ONOO- in pH 7.4 phosphate buffer showed a simple dependence on [ONOO-] (Fig 4.11).
We observed a linear 1st-order dependence in ONOO- concentrations.

Figure 4.11: Effect of [ONOO-] variation on SST-14(SNO) formation in PBS at pH 7.4. Fixed [EDTA] =
100 µM, [SST-14(SH)] = 1 mM. (A) Varied [ONOO-] = (a) 500 µM, (b) 600 µM, (c) 700 µM, (d) 800 µM.
(B) Shows linear relationship between initial rates of SST-14(SNO) formation and ONOO-concentrations for
traces in (A).

EPR spectra using DMPO (Fig 4.12), showed hydroxyl radical production with an increase
in signal intensity as SST-14(SH) concentrations increased. SST-14(SH) by itself in
DMPO at pH 7.4 did not generate any EPR signal. EPR spectra using nitroethane of traces
in Figure 4.11 taken 60s after mixing the reactants, detected NO radicals upon
decomposition of SST-14(SNO). We also observed an increase in NO radicals intensity
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with increased ONOO- concentrations.

Figure 4.12: EPR spectra of DMPO radical adducts ONOO- mediated SST-14(SNO) formation at
pH 7.4. Fixed [ONOO-] = 1 mM and [DMPO]= 50 mM. Varied; (A) [SST-14(SH)] = 600 µM, (B) [SST14(SH)] = 700 µM, and (C) [SST-14(SH)] = 800 µM.

4.2.3.4 Peroxynitrite mediated S-nitrosylation reaction scheme. The reaction dynamics
observed in sections 3.2.3 and 4.2.3, implicate eight reactions (R4.1 – R4.8) as being the
most relevant in ONOO- mediated S-nitrosylation reactions. At pH ≥ 7, the stoichiometry
of thiol S-nitrosylation by ONOO- is shown by R 4.1. Mass spectrometry experiments were
unable to detect the highly unstable sulfenic acid intermediate, which would mostly likely
be formed as a result of two electron transfers from ONOO- to the peptide sulfhydryl group.
We propose this as the pathway for thiol oxidation through sulfenic acid formation and its
subsequent reaction with other thiols to form the disulfide (R4.1). Based on its pKa, we
expect that ONOO- is reasonably protonated and that its decomposition would occur
according to reaction R4.2. Peroxynitrous acid mediated S-nitrosylation is most likely
mediated through thiolate anion nucleophilic attack on peroxynitrous acid, resulting in the
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release of the hydrogen peroxide anion which can subsequently protonated to hydrogen
peroxide (H2O2) (R4.3). Hydrogen peroxide readily diffuses cross the cell membranes and
it is postulated that it can be converted, through the Fenton reaction (R3.16) to the more
toxic •OH radicals in the presence of ferrous ion225-226. Detection of •OH radicals in our
EPR experiments at pH 7.4 supports the feasibility of this reaction mechanism. The
glutathione thiolate anion is known to react with thiyl radicals to generate disulfide radical
anions 227. Analogous reactions occur with other protein Cys residues intramolecularly if
protein/peptide structure allows. When the pH is lower than the pKa of the thiol, the
ONOOH reaction with a thiol would result in oxidation to the disulfide with the release of
NO2- (R4.4). Thiol oxidation could also occur through a one electron transfer mechanism,
resulting in the formation of NO2 and thiyl radicals which would form the disulfide (R4.5
and R4.6).
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Thiyl radical reactions with NO can form S-nitrosocysteine which is regarded as important
product of thiol-dependent signaling228. Kinetic data has shown that disulfides and thiols
are not the only reaction products formed from protein/peptide thiyl reactions even in the
presence of antioxidants 229. Especially at suboptimal levels of antioxidants or when thiyl
radicals are not accessible to antioxidants. The detection of ONOO- -induced tyrosine
radicals in blood plasma of has prompted researchers to question their involvement in
electron transfer with cysteine residues230. Importantly, there is growing evidence that
implicates peptide thiyl radicals in GTPase nucleotide exchange process and other
pathways that promote S-nitrosylation

231-233

. In acidic media, the nitrite ions formed in

reactions R4.1 and R4.4 would be converted to HNO2 in a fast proton-transfer reaction
with an equilibrium determined by nitrous acid’s pKa (R4.5). Nitrous acid reacts with the
peptide thiol to form RSNO and water (R4.6). Our data suggests that ONOOH Snitrosylation reactions are analogous to S-nitrosylation mediated by HNO2, similar reaction
dynamics have been observed for alkyl nitrite (RONO) mediated S-nitrosylation reactions
which are reported to involve the elimination of hydroxyl ions 234.

4.2.3.5 Temperature dependence and thermodynamic parameters. Pseudo first-order kobs
rates for ONOOH and ONOO- S-nitrosylation reactions were obtained from data shown in
Figures 4.9 and 4.11, respectively. The observed kobs rates for ONOOH mediated Snitrosylation spectral results were plotted against [ONOOH], with varied [ONOOH]
concentrations at each temperature (Fig 4.13A) and derived kobs values as stated in Table
4.4. These kobs rates were an order of magnitude below values for ONOOH mediated
AVP(SNO) formation. Cleavage of the disulfide between residue Cys3 and Cys14 in SST91

14 has been linked to altered conformational dynamics and aggregation resulting in
modifications to its native structure, with the thiol-containing structure having a wide range
of conformations and being highly dynamic235. Essentially, SST-14(SH) has increased
conformational dynamics, lower mechanical stability, and increased entropy as compared
to the disulfide. Surprisingly, the conformational flexibility of SST-14(SH) due to
linearization did not result in increased access to thiol residues and higher S-nitrosylation
rates than those for AVP(SH), even though SST-14(SH) autoxidation to the disulfide takes
longer (Table 4.1).

Table 4.4: ONOOH mediated SST-14 S-nitrosylation observed rate constants; kon and koff.
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
11 ± 0.9
15 ± 1.6
26 ± 0.8
37.9 ± 1.1
54 ± 3

koff (s-1)
307.1 ± 27
363 ± 55
723 ± 20
979 ± 43
1137 ± 87

As expected, ONOOH reactions with SST-14(SH) were kinetically and thermodynamically
more favorable as evidenced by the larger kobs values (Table 4.4) and lower Ea, ∆H‡ and
∆G‡ values (Table 4.5) than reactions with ONOO-.
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Table 4.5: ONOOH mediated SST-14 S-nitrosylation thermodynamic parameters.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

45.7

49.3

41.6

-25

44.2

46.1

38
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kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature = 37oC b

Data from kobs rates for ONOO- mediated S-nitrosylation reactions (Fig 4.14) and the
derived kon and koff values (Table 4.6), shows a slow reaction. Thiol oxidation through
sulfenic acid formation and its subsequent reaction with other thiols to form the disulfide
(R4.1) does provide a potential explanation for this. Additionally, the physiological
relevance of ONOO--induced S-nitrosylation cannot be fully understood without
considering the presence of CO2, which is a major physiological target for ONOO-236.
Studies have shown that ONOO- reactions with thiol can be inhibited by adding bicarbonate
(HCO3−; as a source of CO2) in a concentration-dependent manner237. Several mechanisms
have been proposed that involve the reaction between peroxynitrite and bicarbonate
forming various peroxybicarbonate species

238

. Given that carbon dioxide concentrations

in vivo are not high but mainly persist as HCO3− in biological fluids, one could rightly
question whether carbon dioxide and carbonate mediated ONOO- depletion is a major
mechanism for ONOO- detoxification in vivo 239. Kinetic data suggests that in excess CO2,
ONOO- mediated S-nitrosylation reactions produce two-electron oxidation products with
rapid decomposition of nitrosoperoxycarbonate adducts to form nitrogen dioxide and
carbonate radicals

199, 240

. Decomposition of ONOO- in phosphate and bicarbonate buffer
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systems was found to be a least 10 times slower in phosphate buffer, confirming
bicarbonate’s catalytic effect on ONOO- decomposition resulting in NO3- release and the
regeneration of CO2 241. While it may be feasible that dissolved CO2 in our reaction mixture
may deplete some of the initial ONOO-, we emphasize that it’s effect would only be
relevant if bolus amounts of CO2 were present and the rate of ONOO- depletion in
phosphate buffer (1.11 ± 0.01 s−1)241 was rapid enough to out-compete S-nitrosylation
reactions.
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Figure 4.13: (A) Kobs values for the S-nitrosylation of SST-14(SH) by varied ONOOH concentrations. Fixed
[EDTA] = 100 µM, [SST-14(SH)] = 1 mM. Varied [ONOO-]: [H+] on a 1:1 ratio in the range 10-55 mM (B)
and (C) depicts linear erying plots from kon and koff values in Table 4.4 respectively.
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Table 4.6: ONOO- mediated SST-14 S-nitrosylation observed rate constants; kon and koff.
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
0.87 ± 0.14
1.05 ± 0.06
1.14 ± 0.05
1.18 ± 0.2
1.25 ± 0.07

koff (s-1)
165 ± 4.3
171 ± 2.1
220 ± 1.3
225 ± 7.1
269 ± 2.2

Table 4.7: ONOO- mediated SST-14 S-nitrosylation thermodynamic parameters.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

60.7

65.4

58.3

-22.9

53.4

57.6

50.9

21.7

kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature = 37oC b
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Figure 4.14: (A) Observed rate constants for the S-nitrosylation of SST-14(SH) by ONOO-. Fixed [EDTA]
= 100 µM, [STT-14(SH)] = 1 mM. Varied [ONOO-] in the range 10-55 mM. (B) and (C) depicts linear erying
plots from kon and koff values stated in Table 4.6.
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4.2.4 SNAP mediated SST-14(SH) S-nitrosylation.
4.2.4.1 Effect of SST-14 and SNAP variation. We investigated SST-14(SNO) formation
through transnitrosation by SNAP PBS at pH 7.4. The reaction is rapid and complete in
less than 10 secs, with a green to red color which are representative of SNAP and SST14(SNO), respectively (Fig 4.15A). Initial rate plots indicate the first order dependence of
SST-14(SNO) formation on SST-14(SH) concentrations (Fig 4.15B). The effect of varying
sub-stochiometric concentrations of SST-14(SH) on SNAP depletion at 590 nm, also gave
simple first order kinetics (Fig 4.16A-B), with residual absorbance.

Figure 4.15: Effect of [SST-14(SH)] variation on reaction with SNAP in PBS at pH 7.4. Fixed [EDTA] =
100 µM, [SNAP] = 1 mM. (A) Varied [SST-14(SH)] = (a) 400 µM, (b) 500 µM, (c) 600 µM, (d) 700 µM,
(e) 800 µM. (B) Shows linear relationship between initial rates of STT-14(SNO) formation and SST-14(SH)
concentrations for traces in (A).
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Figure 4.16: (A) Effect of [SST-14(SH)] variation on SNAP depletion at 590 nm in PBS at pH 7.4. Fixed
[EDTA] = 100 µM, [SNAP] = 1 mM. (A) Varied [SST-14(SH)] = (a) 200 µM, (c) 300 µM, (d) 400 µM, (e)
500 µM, (f) 600 µM. (B) Shows linear relationship between initial rates of SNAP depletion and SST-14(SH)
concentrations for traces in (A).

The effect of varying SNAP on SNAP depletion and SST-14(SNO) formation is shown in
Figures 4.17 and 4.18 respectively. From kinetic data in Figures 4.16- 4.19 and Eq 3.12,
we determined the bimolecular rate constant for the direct S-nitrosylation of SST-14(SH)
by SNAP to be 261 ± 5.4 M-1s -1.
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Figure 4.17: Depletion of varied SNAP concentrations at 590 nm in PBS at pH 7.4. Fixed [EDTA] = 100
µM, [SST-14(SH)] = 250 µM. (A) Varied [SNAP] = (a) 400 µM, (b) 600 µM, (c) 800 µM, (d) 900 µM, (e)
1 mM (B) Shows linear relationship between initial rates of SNAP depletion and SST-14(SH) concentrations
for traces in (A).
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Figure 4.18: Effect of [SNAP] variation on SST-14(SNO) formation in PBS at pH 7.4. Fixed [EDTA] = 100
µM, [SST-14(SH)] = 1 mM. (A) Varied [SNAP] = (a) 400 µM, (b) 500 µM, (c) 600 µM, (d) 700 µM, (e) 800
µM, (f) 900 µM, (g) 1 mM. (B) Shows linear relationship between initial rates of SST-14(SNO) formation
and [SNAP] concentrations for traces in (A).

4.2.4.2 SST-14(SH) transnitrosylation thermodynamic parameters.
Using methods described in section 3.2.2.5, we ran traces in Fig 4.18 in 10-fold excess of
SNAP (10-55 mM). The kobs rates for SNAP mediated SST-14(SNO) formation were
plotted against [SNAP] at each temperature (Fig 4.19A) and the derived kon and koff values
stated in Table 4.8. Observed kobs rates are less but within range of SNAP mediated
AVP(SNO) formation kobs values (Table 3.8). Derived thermodynamic parameters were;
for kon as Ea = 37.2 kJmol-1 ; ∆H‡on = 34.8 kJ mol-1 and ∆S‡on = -111.1 J mol-1 K-1; for koff
these are Ea = 15.1 kJmol-1; ∆H‡off = 58.9 kJ mol-1 and ∆S‡off = -149.3 J mol-1 K-1) (Table
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4.9). Both ∆S‡on and ∆S‡off entropic parameters are negative, which correlates with
comparable entropic parameters in SNAP mediated AVP(SH) trans-nitrosylating reactions.
The largest difference is the considerably smaller koff activation (15.1 kJmol-1) for SST14(SNO) decomposition than that obtained for AVP(SNO) decomposition. One can
reasonably conclude that SNAP mediated SST-14(SNO) formation is both kinetic and
thermodynamically less favorable than AVP(SNO) formation.

Table 4.8: SST-14(SH) SNAP mediated S-nitrosylation observed kon and koff rate constants.
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
5.2 ± 0.1
6.5 ± 0.6
8.9 ± 1.1
11.8 ± 0.5
13.6 ± 1.4

koff (s-1)
494 ± 3.2
525 ± 21
595 ± 28
633 ± 17
751 ± 45

Table 4.9: SST-14(SH) SNAP mediated S-nitrosylation thermodynamic parameters.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

37.2

69.0

34.8

-111.1

15.1

58.9

13.0

-149.3

kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature = 37oC b
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Figure 4.19: (A) Temperature dependence plot of kobs vs [SNAP] for the reaction with SST-14(SH) in PBS
at pH 7.4. Fixed [EDTA] = 100 µM, [SST-14(SH] = 1 mM. Varied [SNAP] in the range 10-55 mM. (B) and
(C) depicts linear erying plots from kon and koff values in Table 4.8.
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4.3 Conclusion. Autoxidation of SST-14(SH) at physiological temperature and pH took ~
44 mins for 95% SST-14(S-S) reformation, which is sufficient time for thiol S-nitrosylation
reactions to occur. This study has outlined rudimentary steps involved in the S-nitrosylation
of SS-14(SH) by HNO2, ONOO- and SNAP. Acidic conditions that are found protein
membrane microdomains would promote SST-14(SNO) formation through HNO2/NO+
mediated S-nitrosylation. Bimolecular rate constants of 390 ± 56 M-1s-1 and 8.7 x 104 M1 -1

s are reported here for HNO2 and NO+ mediated SST-14(SNO) formation respectively.

Our experiments reveal how peroxynitrite could alter SST-14 function specifically through
cysteine modification after reduction of the peptide thiol. Bimolecular rate constants of 308
± 24 M-1s-1 and 1.5 x 103 M-1s-1 are reported here for ONOO- and ONOOH mediated SST14(SNO) formation respectively. Further studies could focus on deciphering which
cysteine residue is selectively S-nitrosylated first (if any), as has been reported for the
reaction of peroxynitrite with various amino acids242. Reactions between SST-14 with
H2O2 or hydroxyl radicals (R4.3) could lead to SST-14 inactivation through other cysteine
residue modification. Besides modifying Cys, peroxyl radicals are also known to target
tyrosine residues, yielding bityrosine243, a modification not observed for the peroxynitrite
reactions with SST-14(SH). EPR studies confirmed NO radical release from SST-14(SNO)
within timescales that suggest that SST-14(SNO) could be an NO carrier and donor.
Kinetic and thermodynamical data suggests that SNAP mediated SST-14(SNO) formation
is less favorable than AVP(SNO) formation. We also propose that SST-14(SH) is a good
candidate for further studies as a peroxynitrite detoxifying compound. Our findings agree
with growing evidence that implicates small molecular weight thiols as essential effectors
of NO signaling mechanisms.
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CHAPTER 5: KINETICS AND THERMODYNAMICS OF THE REVERSIBLE
BINDING OF NITRIC OXIDE TO UROTENSIN-II
5.1 INTRODUCTION.
Urotensin II (U-II) has the highest vasoconstrictive potency of any mammalian
vasoconstrictor known to man and it’s been implicated in cardiovascular regulation 244-245.
U-II isopeptides have a sequence motif; [Cys-Phe-Trp-Lys-Tyr-Cys] that is conserved in
every isoform (Fig 5.1). Human urotensin II (hU-II) has eleven amino acid residues, and it
is expressed in the CNS and various other organs that makeup the endocrine system 246-247.
Plasma levels of hU-II are elevated in patients with congestive heart failure, liver damage
and hypertension

248-249

. The development of UT receptor antagonists is a hot area of

research, with the hope that they may provide a novel treatment for cardiorenal diseases250.
Sensitive and specific homologous radioimmunoassay used to measure tissue and
circulating levels of U-II, have provided clear evidence that U-II does enter the circulation
and is present in the 10−12‐10−11 M range251. U-II stimulates NO production by upregulating
eNOS expression, which then diffuses into vascular smooth muscle cells thus stimulating
smooth muscle relaxation252. U-II induced vasodilatation has been linked to improved
prognosis in perfused rat hearts after a myocardial ischemic episode 253. Studies on the role
of U-II in females with a pregnancy related complication called intrauterine growth
restriction (IUGR), link elevated U-II thiol-disulfide levels, U-II levels, and oxidative
stress index measurements between the control groups and the cohorts with pregnancies to
the pathophysiology of IUGR254-256.
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Figure 5.1: U-II isopeptides sequences conserved in vertebrates. [Adapted from Francesco Merlino,
Salvatore Di Maro, Ali Munaim Yousif, Michele Caraglia, Paolo Grieco, "Urotensin-II Ligands:
An Overview from Peptide to Nonpeptide Structures", Journal of Amino Acids, vol. 2013, Article
ID 979016, 15 pages, 2013.]257.

Despite documented co-localization of U-II and NO, there has been no research into NOmediated S-nitrosylation reactions that have the potential to alter U-II thiol-disulfide levels
and U-II/UT receptor interactions that may be linked to various pathologies. This chapter
will explore kinetic and thermodynamic parameters of U-II S-nitrosothiol (U-II(SNO))
formation through reactions involving NO moieties.
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5.2 RESULTS AND DISCUSSION
5.2.1 U-II thiol formation and stability. We extrapolated methods described in section
3.2.1 to investigate U-II thiol (U-II(SH)) half-lives using HPLC (Fig 5.2). Ƹ280 of U-II
disulfide (U-II(S-S) and U-II(SH) were determined to be 7115 M-1cm-1 and 6990 M-1cm-1,
respectively (Eq 5.1). Chromatogram (A, Figure 5.2) was derived from a standard sample
of 20µM U-II(S-S) eluting at 1.87 min. Chromatogram (B) shows product elution at 1.51
min after incubation of 15µM U-II(S-S) with 400 µM TCEP for 30 min. Mass
spectrometric analysis of the standard ((chromatogram (A)), identifies eluant as U-II(S-S)
with singly protonated (M+H) + ions at m/z 1388.56 and the doubly protonated (M+2H)2+
ions at m/z 694.78 (Fig 5.3A). The product (chromatogram (B) was identified as the singly
protonated [(M+H) +] thiol at m/z 1390.58 and the doubly protonated [(M+2H)2+] thiol at
m/z 695.79 (Fig 5.3B).

Ƹ280 = (# 𝑇𝑟𝑦𝑝𝑡𝑜𝑝ℎ𝑎𝑛 × 5500) + (# 𝐶𝑦𝑠𝑡𝑒𝑖𝑛𝑒 × 125) + (# 𝑇𝑦𝑟𝑜𝑠𝑖𝑛𝑒 × 1490) 𝐸𝑞 5.1

Variation of temperature, pH, and the effect of metal chelators on U-II(S-S) reformation
through disulfide reduction was evaluated using HPLC-UV according to equation 3.1. The
time course for U-II(S-S) reformation is summarized in Table 5.1. The half-life of U-II(SH)
at physiological pH and temperature was determined to be 33.2 mins. As previously
described for AVP(SH) and SST-14(SH), we also found U-II(S-S) autoxidation to be slow
in acidic media in the absence of a catalyst.
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Figure 5.2: HPLC-UV analysis of U-II(S-S) reduction. (A) A chromatogram of 20µM U-II(S-S)
was run as a standard and eluted at 1.32 mins. (B) 15µM U-II(S-H) in pH 3 water was incubated
for 30 minutes in 600 µM TCEP (40-fold excess), the product was eluted at 1.51 mins.

An increase in temperature from 25 - 50 °C resulted in a 5-fold enhancement in the rate of
U-II autoxidation in acid media. Experiments at physiological pH gave U-II(SH) half-lives
of 81 mins and 33.2 mins at 25 °C and 37 °C respectively. Metal chelators had an inhibitory
effect on U-II(S-S) reformation.
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Figure 5.3: ESI-MS analysis of HPLC chromatograms in Fig 5.2. (A) ESI mass spectra confirmed
chromatogram A as U-II disulfide. (B) ESI mass spectra confirms chromatogram B as U-II thiol.
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Table 5.1. The effects of temperature, pH, and copper chelators on required for U-II(S-S)
reformation.

Data presented in Table 5.1 is applicable for chemical optimization strategies aimed at
discovering therapeutic tools for disorders linked to U-II derivatives, peptides or
nonpeptide analogues. Studies into structure-activity relationship pertaining to U-II(SS)/(SH) exchange reactions would provide useful insights with regards to
pharmacodynamic and pharmacokinetic properties that can be used to mitigate the
accumulation of undesirable metabolites in tissues. It is still unclear how the stability of UII(SH) affects U-II’s affinity for the UT receptor. Advances in the optimization of
oligopeptides as UT receptor antagonists are poised to lead to powerful pharmacological
tools streamlining the role of autogenous U-II species in a plethora of pathophysiological
processes. Based on the reported half-lives of U-II(SH) in Table 5.1 and the potential for
co-localization with NO, we proceeded to investigate the possible subsequent Snitrosylation reactions.
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5.2.2 Reaction kinetics and thermodynamics
5.2.2.1 Nitrous acid mediated U-II(SH) S-nitrosylation. A multiscan UV spectrum of
reactants and products depicts HNO2 (Fig 5.4a) and NO2- (Fig 5.4b) with an absorptivity
coefficient of 22.9 M-1cm-1 at 355 nm. The product of a reaction between U-II(SH) and
HNO2, shows distinct absorbance peaks at 335 nm and 545 nm (Fig 5.4c) which are
attributed to the S-nitrosothiol; U-II(SNO). The peaks for U-II(S-S) (Fig 5.4d) and UII(SH) (Fig 5.4e) are depicted at 280 nm with absorptivity coefficients 7115 M-1cm-1 and
6990 M-1cm-1 respectively.

5.2.2.2 Effect of nitrite variation. The effect of NO2- variation on U-II(SNO) formation
followed simple first order kinetics with regards to [NO2-]0 (Fig 5.5).

5.2.2.3 Effect of acid on U-II(SNO) formation. The effect of acid variation adhered to
similar trends as those reported for AVP(SH) and SST-14(SH) reactions with HNO2 as
seen in Figure 5.6. When [NO2-]0 > [H+]0, the concentration of HNO2 is the limiting
reagent, and we observed a gradual increase in U-II(SNO) formation upon an increase in
[H+]0 (Fig 5.6A, traces (a)-(c)). Traces (d)-(f) depict reaction conditions where [H+]0 ≥
[NO2-]0, with a continued increase in U-II(SNO) formation even with excess [H+]0, which
implicates NO+ mediated U-II(SNO) formation according to reaction R3.4.
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Figure 5.4: Spectra scan of; (a) [HNO2-] = 16 mM, (b) [NO2-] = 27 mM, (c) [U-II] = 1 mM, [NO2-]

= 5 mM and [H+] = 5 mM, (d) [U-II(S-S)] = 77 µM and (e) U-II(SH) = 32 µM.

Initial rate plots gave a sigmoidal curve (Fig 5.6B) with a steep increase in U-II (SNO)
formation corresponding to increase in [H+]0 when [NO2-]0 > [H+]0 , followed by an
inflection point at [H+]0 ≥ [NO2-]0 (Fig 5.6B trace (d)), after which U-II (SNO) formation
rates plateau due to U-II(S-H) depletion. Using Eq 3.7 (section 3.2.2.4) and Fig 5.6, we
determined the bimolecular rate constants for U-II(SH) S-nitrosylation by HNO2 and NO+
to be 722 ± 43 M-1s-1 and 1.3 x104 M-1s-1.
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Figure 5.5: (A) Effect of [NO2-] variation on U-II(SNO) formation. Fixed [H+] = 1 mM, [EDTA] = 100 µM,
[U-II(S-S)] = 1 mM. Varied [NO2-] = (a) 400 µM, (b) 500 µM, (c) 600 µM, (d) 700 µM. (B) Initial rate plot
shows strong dependence of U-II(SNO) formation on NO2- concentration.
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Figure 5.6: Effect of [H+] variation on U-II(SNO) formation. (A) Fixed [U-II(SH)] = 800 µM, [EDTA] =
100 µM, [NO2-] = 800 µM. Varied [H+] = (a) 100 µM, (b) 300 µM, (c) 500 µM, (d) 800 µM, (e) 1 mM, (f)
1.2 mM. (B) Initial rate plot shows 1st-order dependence of U-II(SNO) formation initial rates on acid, with
continued increase at high acid concentrations leading to saturation.
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5.2.2.4 Effect of U-II(SH) variation. Increments in U-II(SH) concentrations resulted in
increased rates of U-II(SNO) formation where [NO2-]0 and [H+]0 > [U-II(SH)]0 (Fig 5.7).
Rate plots were linear with a first order dependence on [U-II(SH)] with an intercept
kinetically indistinguishable from zero (Fig 5.7B).

Figure 5.7: The reaction between U-II(SH) and HNO2 exhibits 1st-order kinetics in U-II(SH). (A) Effect of
varying U-II(SH) concentrations on U-II(SNO) formation. Fixed [NO2-] = 1 mM, [EDTA] = 100 µM, [H+]
= 1 mM. Varied [U-II(SH)] = (a) 100 µM, (b) 300 µM, (c) 500 µM, (d) 800 µM, (e) 900 µM. (B) Initial rate
plots a linear dependence of U-II(SNO) formation rates on [U-II(SH)].

5.2.2.5 Thermodynamic parameters for NO+ mediated U-II(SNO) formation. Using
methods described in section (section 3.2.2.5) and traces in Figure 5.6, we obtained Figure
5.8A which depicts a plot of varied [HNO2] against kobs rates at each temperature, and
derived kon and koff values (Table 5.2). Rates of kobs for NO+ mediated U-II(SNO) formation
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were lower than those for SST-14(SNO) formation but within the same order of magnitude.
The slope and intercept values from erying plots for kon and koff (Fig 5.8B and Fig 5.8C)
respectively were used to calculate thermodynamic parameters; for kon and koff (Table 5.3).
Table 5.2. NO+ mediated U-II S-nitrosylation observed rate constants: kon and koff.
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
5.4 ± 0.1
8 ± 0.2
12.6 ± 0.4
14 ± 1
17.3 ± 0.5

koff (s-1)
89 ± 2.9
107 ± 7.4
161 ± 9
196 ± 40
288 ± 16

Table 5.3: NO+ mediated U-II(SH) S-nitrosylation thermodynamic parameters.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

42.8

67.9

40.3

-90

43.6

60.8

40.9

65

kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature = 37oC b

A relatively poorer agreement was found with regards to the magnitude of ∆S‡ values, as
a result of experimental temperature fluctuations that led to some extrapolated values of
∆S‡ being outside of standard deviations limits. Despite these shortcomings, our data gave
constantly negative kon entropy values for NO+ mediated AVP(SNO), SST-14(SNO) and
U-II(SNO) formation reactions, which further supports our evaluation of an associative
mechanism with an unstable transition state. A strong agreement is shown with regards to
positive koff entropy values which describes a dissociative mechanism for target peptide
SNO decompositions.
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Figure 5.8: (A) Observed rate constants for the S-nitrosylation of U-II(SH) by varied HNO2 concentrations.
Fixed [EDTA] = 100 µM, [U-II] = 1 mM. Varied [HNO2] in the range 10-55 mM. (B) and (C) depicts linear
Erying plots from kon and koff values stated in Table 5.2 respectively.
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5.2.3 Peroxynitrite-mediated U-II(SH) S-nitrosylation.
5.2.3.1 Effect of U-II(SH) variation. All ONOO- mediated U-II(SH) S-nitrosylation
kinetic experiments were conducted in mildly acidic media and at pH 7.4 in phosphate
buffer according to reactions R3.10- R3.12. Depletion of ONOO- was monitored as
described in section 3.2.3. Rates of U-II(SNO) formation showed a linear first order
dependence on [U-II(SH)] (Fig 5.10). We evaluated the bimolecular rate constant for the
S-nitrosylation of U-II(SH) by ONOO- to be 460 ± 15 M-1s-1. Rates of ONOO- depletion
by U-II(SH) shows rapid autocatalytic decay kinetics with residual absorbance due to
[ONOO-] in excess of that of [U-II(SH)] (Fig 5.11A). Rate plots gave a non-zero yintercept corresponding to the rate of ONOO- decomposition in the absence of U-II(SH)
(Fig 5.11B).

118

Figure 5.10: Effect of varying U-II(SH) concentration on U-II(SNO) formation in pH 7.4 PBS. Fixed
[EDTA] = 100 µM, [ONOO-] = 1 mM. (A) Varied [U-II(SH)] = (a) 100 µM, (b) 300 µM, (c) 400 µM, (d)
600 µM, (e) 700 µM. (B) Shows linear relationship between initial rates of U-II(SNO) formation and UII(SH) concentrations for traces in (A).
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Figure 5.11: Effect of varying U-II(SH) concentration on ONOO- depletion in pH 7.4 PBS. Fixed [EDTA]
= 100 µM, [ONOO-] = 1 mM. (A) Varied [AVP(SH)] = (a) 300 µM, (b) 400 µM, (c) 500 µM, (d) 600 µM,
(e) 700 µM. (B) Shows linear relationship between initial rates of ONOO - depletion and U-II(SH)
concentrations for traces in (A).

5.2.3.2 Effect of acid variation on ONOOH depletion and U-II(SNO) formation.
The rates of ONOO- depletion by U-II(SH) increased with added acid concentrations as
formation of the conjugate acid, ONOOH, catalyzed the reaction (Fig 5.12A). A nonlinear
curve is obtained from initial rate plots (Fig 5.12B) for the reaction of U-II(SH) and
ONOOH at 25oC. Kinetics of ONOOH mediated U-II(SNO) formation showed similar
dependence on acid as previously described for AVP(SH) and SST-14(SH) reactions with
ONOOH. Increasing acid where [H+] < [ONOO-] (Fig 5.13) showed linearity characteristic
of a direct function of increase in H+ (Fig 5.13).

120

Figure 5.12: (A) Effect of varying H+ concentration on ONOO- depletion. Fixed [U-II(SH)] = 800 µM,
[EDTA] = 100 µM, [ONOO-] = 1 mM. Varied [H+] = (a) 200 µM, (b) 250 µM, (c) 300 µM, (d) 350 µM, (e)
400 µM, (f) 450 µM and (g) 500 µM (B) Initial rates plot shows an exponential increase in ONOOdepletion with increased acid concentrations.

Figure 5.13: (A) Effect of varying H+ concentration on ONOO- mediated U-II(SNO) formation. Fixed [UII(SH)] = 1 mM, [EDTA] = 100 µM, [ONOO-] = 1 mM. Varied [H+] = (a) 600 µM, (b) 700 µM, (c) 800 µM,
(d) 900 µM. (B) Initial rate plot shows a linear relationship between acid concentration and U-

II(SNO) formation
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5.2.3.4 Peroxynitrite variation and EPR analysis. A familiar simple linear dependence on
ONOO- concentrations at pH 7.4 was also observed for the reaction with U-II(SH) in pH
7.4 phosphate buffer (Fig 5.14). Our data shows commonality in the manner ONOO- reacts
with target peptide thiols. These apparent second-order rate constants of ONOO- with thiols
are well described in literature, with numerous studies agreeing with our data that ONOOmediated thiol oxidation reaction mechanisms are first order in ONOO- and the target258259

. EPR spectra with DMPO shows typical hydroxyl radical production from the Fenton’s

reaction as a control (Fig 5.15A). Figure 5.15; traces B-C, shows spectra similar to trace
(A), with an increase in signal intensity that corresponds to added U-II(SH). Whilst Figure
5.15D, shows the quenching effect of adding the hydroxyl radical scavenger mannitol.

5.2.3.5 Thermodynamic parameters for ONOO-/ONOOH mediated U-II(SNO)
formation. We ran traces in Figures 5.13 and 5.14 under pseudo-first-order conditions with
10-fold (10-55 mM) excess of ONOOH and ONOO- respectively. Figure 5.16A, shows kobs
plots of ONOOH mediated U-II(SNO) formation. Surprisingly, we observed kobs values for
ONOOH (Table 5.4) that closely resembled those recorded for NO+ S-nitrosylations (Table
5.2). Derived thermodynamic parameters were; for kon as Ea = 37.2 kJmol-1 ; ∆H‡on = 42.7
kJ mol-1 and ∆S‡on = -80.3 J mol-1 K-1; for koff these are Ea = 45.1 kJmol-1; ∆H‡off = 38 kJ
mol-1 and ∆S‡off = 155 J mol-1 K-1) (Table 5.5). Figure 5.17A, shows kobs plots of ONOOmediated U-II(SNO) formation. As expected, observed kobs values for ONOO- (Table 5.6)
are an order of magnitude smaller than ONOOH mediated S-nitrosylations (Table 5.4).
Derived thermodynamic parameters were; for kon as Ea = 61.4 kJmol-1; ∆H‡on = 58.9 kJ
mol-1 and ∆S‡on = -10 J mol-1 K-1; for koff these are Ea = 43 kJmol-1; ∆H‡off = 55 kJ mol-1
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and ∆S‡off = 17 J mol-1 K-1) (Table 5.7).

Figure 5.14: Effect of [ONOO-] variation on U-II(SNO) formation in phosphate buffer pH 7.4. Fixed
[EDTA] = 100 µM, [U-II(SH)] = 1 mM. (A) Varied [ONOO-] = (a) 300 µM, (b) 500 µM, (c) 600 µM, (d)
700 µM. (B) Shows linear relationship between initial rates of U-II(SNO) formation and ONOOconcentrations for traces in (A).

123

Figure 5.15: EPR spectra of OH radical adducts produced during ONOO- mediated U-II(SNO)

formation at pH 7.4. Spectra was collected immediately upon mixing reactants at room temperature.
(A) Fenton’s reaction; [H2O2] = 0.1M, [FeSO4] = 0.025M, [DMPO]= 50 mM. Spectra (B-D) had fixed
[ONOO-] = 1 mM, and [DMPO]= 50 mM. (B) [U-II(SH)] = 500 µM, (C) [U-II(SH)] = 700 µM. (D) [UII(SH)] = 900 µM and [Mannitol]= 1.5 mM
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Figure 5.16: (A) Observed rate constants for the S-nitrosylation of U-II(SH) by varied ONOOH
concentrations. Fixed [EDTA] = 100 µM, [U-II(SH)] = 1 mM. Varied [ONOO-]: [H+] on a 1:1 ratio in the
range 10-55 mM (B) and (C) depicts linear Erying plots from kon and koff values that are stated Table 5.4
respectively.
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Table 5.4: Observed rate constants for ONOOH mediated U-II(SH) thiol S-nitrosylation
reactions.
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
7.5 ± 0.2
8.7 ± 0.5
17.6 ± 1.5
18 ± 1
24 ± 1.3

koff (s-1)
187 ± 4
192 ± 13
241 ± 28
258 ± 35
277 ± 33

Table 5.5: Thermodynamic parameters for ONOOH mediated U-II(SH) thiol Snitrosylation reactions.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

37.2

67.4

42.7

-80.3

45

61.1

38

155

kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature = 37oC b
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Figure 5.17: (A) Observed rate constants for the S-nitrosylation of U-II(SH) by varied ONOO- concentrations
over a broad temperature range of 15-35 oC in PBS at pH7.4. Fixed [EDTA] = 100 µM, [U-II(SH)] = 1 mM.
Varied [ONOO-] in the range 10-55 mM (B) and (C) depicts linear erying plots from kon and koff values that
are stated Table 5.6 respectively.
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Table 5.6: Observed rate constants for ONOO- mediated U-II(SH) thiol S-nitrosylation
reactions.
Temp (oC)
15
20
25
30
35

kon (M-1s-1)
0.3 ± 0.02
0.36 ± 0.3
0.7
0.84 ± 0.05
0.89 ± 0.07

koff (s-1)
156 ± 0.8
163 ± 1.2
175 ± 0.5
188 ± 2.1
205. ± 2.8

Table 5.7: Thermodynamic parameters for ONOO- mediated U-II(SH) thiol Snitrosylation reactions.
Eaa

ΔG‡b

ΔH‡c

ΔS‡d

61.4

62.0

58.9

-10

43.0

49.8

55.0

17

kon

koff

a, b and c

Values are in kJ/mol, whilst d values are in J.mol-1K-1. Temperature = 37oC b
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5.3 Conclusion. The reaction dynamics and mechanisms involved in U-II(SNO) formation
through oxidation by HNO2 and ONOO- are similar to those reported in this study for
AVP(SNO) and SST-14(SNO) formation reaction. In acidic media, the major nitrosants
are HNO2 and NO+, our kinetic data does not provide and evidence for the role of N2O3 as
a nitrosating agent as reported in S-nitrosoglutathione (GSNO) formation from NO and
excess glutathione231. U-II(SNO) also seems to have sufficient half-life (~ 5s) under
physiologically relevant conditions to be an efficient NO carrier. Copper catalyzed UII(SNO) formation and decomposition suggesting a complex dynamic that is largely
dependent on the presence of transition metal ions and cofactors in the physiological
milieu. Even though our bimolecular rate constants for U-II(SNO) formation pale in
comparison to those reported for GSNO, we propose that co-localization of U-II(SH) and
NO would be the key to U-II(SNO) production in vivo. At pH 7.4, our data shows ONOOand SNAP as kinetically and thermodynamically favorable nitrosating agents with the
potential reformation of disulfides in the case of ONOO-. Oxidative mechanisms
implicated in the etiology of heart failure and liver disease are curiously accompanied by
upregulation in U-II expression

260

, it would be interesting to probe the possibility of a

correlation between U-II thiol and U-II(SNO) formation with disease etiology.
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CHAPTER 6: SUMMARY, CONCLUSIONS AND FUTURE PERSPECTIVES
6.1. SUMMARY
Peptide thiol stability and the formation of SNOs from neuropeptides; arginine vasopressin
(AVP), somatostatin-14 (SST-14) and urotensin II (U-II) were studied. Investigations into
the effects of temperature, copper chelators and pH on peptide disulfide reformation show
that AVP, SST-14 and U-II thiols have half-lives of 30, 44 and 28.2 mins respectively at
physiologically relevant temperature and pH in the absence of metal chelators. Target
peptide thiols were shown to have half-lives sufficient for subsequent S-nitrosylation
reactions.

This study also reports that S-nitrosothiols: AVP(SNO), SST-14(SNO) and U-II(SNO) are
produced by HNO2 and NO+ mediated S-nitrosylations. The reaction dynamics suggest
only four reactions (R3.3- R3.6) as being relevant in the production of SNOs by HNO2.
Nitrite is initially protonated to produce HNO2 followed by the production of NO+ and the
reaction of HNO2/NO+ with peptide thiols. Reported bimolecular rate constants suggests
that HNO2 and NO+ would be efficient and the predominant nitrosating agents at low pH
(Table 6.1). However, our data does not show a good correlation between primary peptide
structure with increased susceptibility to S-nitrosylation.
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Table 6.1: HNO2/NO+ mediated S-nitrosylations bimolecular rate constants (M-1s-1)
S-nitrosothiol

Nitrosating agent
HNO2

NO+

AVP(SNO)

278 ± 10

2.24 x103

SST-14(SNO)

390 ± 56

8.7 x104

U-II(SNO)

722 ± 43

1.3 x104

Using Reactions R3.3- R3.6, together with HPLC-MS data we propose Scheme 6.1 for
reactions occurring in solutions with peptide thiol and HNO2/NO+ 261. At high HNO2/NO+
concentrations, pathway (A1-A2) would be favored, giving doubly S-nitrosylated SNO.

Scheme 6.1: Proposed reactions of peptide thiols with HNO 2

Pathway (B) resulting in disulfide reformation would be favored low HNO2 and high thiol
concentrations. Therefore, the intramolecular nucleophilic attack on the SNO sulfur occurs
below the pKa of HNO2, even though thiols are usually much less reactive under acidic
conditions. We have established that S-nitrosation of peptide thiols by HNO2 at low pH
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would be the most likely physiologically relevant S-nitrosylation/de-nitrosylation pathway.

Results from this study show the effectiveness of copper chelators; neocuproine (Cu+) and
DTPA (Cu2+) in decelerating copper-catalyzed peptide thiol autoxidation. We also
elucidated the competitive kinetics involved in both SNO formation and decomposition as
discussed in terms of redox cycling that occurs between Cu2+ and Cu+ (R3.1 and R3.2). We
propose Scheme 6.2 for reactions involving copper catalyzed SNO decomposition109, 147,
261

.

Scheme 6.2: Proposed scheme for Cu+ catalyzed SNO decomposition

Peroxynitrite mediated peptide SNO formation reactions are complex with two distinct
nitrosating agents; (i) ONOO- (at pH 7.4) and (ii) ONOOH with possibly HNO2 in acidic
media.

The kinetics and mechanism of peroxynitrite S-nitrosylation reactions were

characterized by rapid SNO formation, with acid as a catalyst for both SNO formation and
decomposition. The reaction dynamics observed in this study implicates eight reactions
(R4.1 – R4.8) as being the most relevant in ONOO- mediated S-nitrosylation reactions.
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Bimolecular rate constants for ONOO-/ONOOH mediated S-nitrosylations (Table 6.2),
depict ONOOH as a more robust nitrosating agent than its conjugate base, largely due to
formation of HNO2 with leads to increased SNO production (R 4.7 and R 4.8). Our data
suggests novel roles for peptide thiols as antioxidant species that counteract damaging
effects of RNOS. The neuropeptides in this study may serve as efficient scavengers which
would effectively mop up excess peroxynitrite and mitigate peroxynitrite-induced
oxidative injury. The reported half-lives of peptide SNOs, suggests that these
neuropeptides may also have crucial roles as carriers and reservoirs for NO bioactivity in
the physiological enviro nments. Studies report that endogenous S-nitrosohaemoglobin has
an essential role in regulating blood homeostasis, whilst SNAP inhibits platelet aggregation
and facilitates vasodilation262-263.

Table 6.2: Bimolecular rate constants (M-1s-1) for ONOO-/ONOOH mediated Snitrosylations
S-nitrosothiols

Nitrosating agents
ONOO-

ONOOH

AVP(SNO)

884 ± 31

1.72 x 104

SST-14(SNO)

308 ± 24

1.55 x 103

U-II(SNO)

572 ± 45

2.4 x 103

Our results suggest that transfer of NO from RSNO to thiols is a direct process without the
formation of free NO as an intermediate. We propose that nucleophilic attack by peptide
sulfhydryl’s on RSNO is fast (as evidence by kinetic data) and facile under physiological
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conditions and insensitive to transition metal ions (R3.21). We therefore propose Scheme
6.3 for elementary two consecutive steps (A-B) involved peptide thiol transnitrosation by
SNAP leading to the production either singly and/or doubly S-nitrosylated SNOs182, 206, 261.
The main factors that govern whether singly/doubly S-nitrosylated SNOs are formed is
largely dependent on reactant concentrations, peptide sequence, hydrophobicity and
electronic environment. The highly negative activation entropy for transnitrosation
reaction suggests that these rate-limiting elementary steps of the transnitrosylation process
are characterized by a relatively ordered associative transition state. These activation
parameters suggest low energy barriers for transnitrosylation under physiological
conditions and support growing evidence that transnitrosylation may be a viable
posttranslational mechanism for NO transport in vivo.

Scheme 6.3: Proposed mechanism for reactions involving peptide thiol transnitrosation by SNAP.
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6.2. CONCLUSIONS AND FUTURE PERSPECTIVES
This dissertation presents neuropeptide RSNOs as good candidates deserving of more
attention as efficient NO carrier and donor compounds for numerous diagnostic and
therapeutic applications. The rapid decomposition rates of these SNOs at physiological pH
7.4, may limit applicability as biomedical tools but slight modifications in structure could
prolong their durability. This could be accomplished by covalently bonding RSNOs to the
polymer backbone of hydrophobic macromolecules. Kinetic and thermodynamic
parameters outlined in this work can serve as the basis for developing these polymers. The
observed catalytic effect of Cu2+ and Cu+ in stimulating SNO formation and decomposition
respectively can be used to designing biomedical devices with the capacity for gradual and
continuous release of NO. Further work could include in vivo detection of these
neuropeptide SNOs. Since AVP, SST-14 and U-II are hormones that can be detected and
isolated from biological fluids, it would be immensely informative to conduct a comparison
of cross-reactivities between neuropeptide immunoglobulins and neuropeptide thiol and Snitrosothiol species. Antibodies could be designed specifically against the thiol and SNO
species to detect these species in vivo. Additional, in vitro studies could be performed using
recombinant peptide receptors, where the affinity and specificity of disulfide, thiol and
SNO species could be evaluated.

This dissertation provides essential insights regarding kinetic, thermodynamic and
mechanistic parameters of novel neuropeptide S-nitrosylation reactions as well as an
analysis of SNO stabilities of that can aid in the design of SNOs with better
pharmacokinetic properties. The protocols, kinetic models and thermodynamic parameters
135

from this study are expected to elucidate key steps toward understanding mechanistic
processes by which S-nitrosylation may alter neuropeptide protein function. Researchers
can use these insights in the development of potential therapeutics that target endogenous
SNOs, and/or utilize synthetic SNOs to stimulate or inhibit NO-signaling in pathologies in
where NO-signaling is clearly implicated. Kinetic models presented in this work can be
used to infer the NO release profile of potential NO-donor based drugs by enhancing our
understanding of the underlying pharmacokinetics.
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